Mut_pos	HLA	Peptide	Core	Of	Gp	Gl	Ip	Il	Icore	Identity	Score	Aff(nM)	%Rank	BindLevel_mut	Ref_pos	HLA	Peptide	Core	Of	Gp	Gl	Ip	Il	Icore	Identity	Score	Aff(nM)	%Rank	BindLevel_ref	NM_accessions	nChange	aaChange	typeChange	mutPeptide	refPeptide	#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	/icgc/dkfzlsdf/project/OE0422/immuno_patients_nct/sequencing/exon_sequencing/view-by-pid/IPNCT_HB60/tumor/paired/merged-alignment/.merging_0/tumor_IPNCT_HB60_merged.mdup.bam	SEQUENCE_CONTEXT	INFO_control(VAF=variant_allele_fraction;TSR=total_variant_supporting_reads_incl_lowqual)	ANNOTATION_control	DBSNP	1K_GENOMES	ANNOVAR_FUNCTION	GENE	EXONIC_CLASSIFICATION	ANNOVAR_TRANSCRIPTS	SEGDUP	CYTOBAND	REPEAT_MASKER	DAC_BLACKLIST	DUKE_EXCLUDED	HISEQDEPTH	SELFCHAIN	MAPABILITY	SIMPLE_TANDEMREPEATS	CONFIDENCE	RECLASSIFICATION	PENALTIES	seqBiasPresent_1	seqingBiasPresent_1	seqBiasPresent_2	seqingBiasPresent_2	Enhancers	CpGislands	TFBScons	ENCODE_DNASE	miRNAs_snoRNAs	miRBase18	COSMIC	miRNAtargets	CgiMountains	phastConsElem20bp	ENCODE_TFBS	mutPosInEpitope
15	HLA-A*01:01	ISCEDASQAEM	ISDASQAEM	0	2	2	0	0	ISCEDASQAEM	2l2_NM_00100518	0.2000760	5738.8	1.7373	WB	15	HLA-A*01:01	VSCEDASQAEM	VSDASQAEM	0	2	2	0	0	VSCEDASQAEM	2l2_NM_00100518	0.1832280	6886.3	2.0746	nonB	NM_001005189	c.G574A	p.V192I	protein-altering	QINHYFCDISPLLNISCEDASQAEMVDFF	QINHYFCDISPLLNVSCEDASQAEMVDFF	1	158517322	.	C	T	225	PASS	DP=384;VDB=3.574027e-01;RPB=-7.458067e-01;AF1=0.5;AC1=1;DP4=88,90,67,71;MQ=60;FQ=225;PV4=0.92,0.22,1,1;ACGTNacgtnPLUS=0,39,0,42,0,0,43,0,60,0;ACGTNacgtnMINUS=0,47,0,29,0,0,75,0,38,0	GT:PL:GQ	0/1:255,0,255:99	TCACAGGAGA,GTTAAGGAGT	DP=171;DP5=73,96,0,0,0;DP5all=74,97,0,0,0;ACGTNacgtnHQ=0,73,0,0,0,0,96,0,0,0;ACGTNacgtn=0,74,0,0,0,0,97,0,0,0;VAF=0.00;TSR=0;PBINOM=1.33638235504609e-51	somatic	.	.	exonic	OR6Y1	nonsynonymous SNV	OR6Y1:ENST00000302617.3:exon1:c.G574A:p.V192I,	.	1q23.1	.	.	.	.	3715;normScore=18.4	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	1
6	HLA-A*01:01	FCDISPLLNI	FCDISPLLI	0	8	1	0	0	FCDISPLLNI	2l2_NM_00100518	0.2285560	4216.9	1.3341	WB	6	HLA-A*01:01	FCDISPLLNV	FCDISPLLV	0	8	1	0	0	FCDISPLLNV	2l2_NM_00100518	0.2398960	3730.0	1.2154	WB	NM_001005189	c.G574A	p.V192I	protein-altering	QINHYFCDISPLLNISCEDASQAEMVDFF	QINHYFCDISPLLNVSCEDASQAEMVDFF	1	158517322	.	C	T	225	PASS	DP=384;VDB=3.574027e-01;RPB=-7.458067e-01;AF1=0.5;AC1=1;DP4=88,90,67,71;MQ=60;FQ=225;PV4=0.92,0.22,1,1;ACGTNacgtnPLUS=0,39,0,42,0,0,43,0,60,0;ACGTNacgtnMINUS=0,47,0,29,0,0,75,0,38,0	GT:PL:GQ	0/1:255,0,255:99	TCACAGGAGA,GTTAAGGAGT	DP=171;DP5=73,96,0,0,0;DP5all=74,97,0,0,0;ACGTNacgtnHQ=0,73,0,0,0,0,96,0,0,0;ACGTNacgtn=0,74,0,0,0,0,97,0,0,0;VAF=0.00;TSR=0;PBINOM=1.33638235504609e-51	somatic	.	.	exonic	OR6Y1	nonsynonymous SNV	OR6Y1:ENST00000302617.3:exon1:c.G574A:p.V192I,	.	1q23.1	.	.	.	.	3715;normScore=18.4	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	10
9	HLA-A*01:01	AFYTNVQPHSY	ATNVQPHSY	0	1	2	0	0	AFYTNVQPHSY	3l3_NM_00100413	0.3220230	1533.9	0.6496	WB	9	HLA-A*01:01	AFYTNVLPHSY	FTNVLPHSY	1	1	1	0	0	FYTNVLPHSY	3l3_NM_00100413	0.3510410	1120.6	0.5184	WB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	7
10	HLA-A*01:01	FYTNVQPHSYH	FTNVQPHSY	0	1	1	0	0	FYTNVQPHSY	3l3_NM_00100413	0.1940870	6123.0	1.8427	WB	10	HLA-A*01:01	FYTNVLPHSYH	FTNVLPHSY	0	1	1	0	0	FYTNVLPHSY	3l3_NM_00100413	0.2216980	4541.7	1.4132	WB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	6
10	HLA-A*01:01	FYTNVQPHSY	FTNVQPHSY	0	1	1	0	0	FYTNVQPHSY	3l3_NM_00100413	0.5639840	111.9	0.0992	SB	10	HLA-A*01:01	FYTNVLPHSY	FTNVLPHSY	0	1	1	0	0	FYTNVLPHSY	3l3_NM_00100413	0.5925890	82.1	0.0773	SB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	6
11	HLA-A*01:01	YTNVQPHSYH	YTNVQPHSY	0	0	0	0	0	YTNVQPHSY	3l3_NM_00100413	0.3177860	1605.8	0.6718	WB	11	HLA-A*01:01	YTNVLPHSYH	YTNVLPHSY	0	0	0	0	0	YTNVLPHSY	3l3_NM_00100413	0.3412640	1245.6	0.5593	WB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
11	HLA-A*01:01	YTNVQPHSY	YTNVQPHSY	0	0	0	0	0	YTNVQPHSY	3l3_NM_00100413	0.7176090	21.2	0.0183	SB	11	HLA-A*01:01	YTNVLPHSY	YTNVLPHSY	0	0	0	0	0	YTNVLPHSY	3l3_NM_00100413	0.7334900	17.9	0.0153	SB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
10	HLA-A*01:01	FSFVQPSLGF	FSFVQPSLF	0	8	1	0	0	FSFVQPSLGF	5l5_NM_00100841	0.2309100	4110.8	1.3078	WB	10	HLA-A*01:01	FSFVQSSLGF	FSFVQSSLF	0	8	1	0	0	FSFVQSSLGF	5l5_NM_00100841	0.2382250	3798.0	1.2325	WB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	6
13	HLA-A*01:01	KTVDSVVPCF	KTDSVVPCF	0	2	1	0	0	KTVDSVVPCF	9l7_NM_00116669	0.2144890	4910.1	1.5123	WB	13	HLA-A*01:01	KTDDSVVPCF	KTDDSVVCF	0	7	1	0	0	KTDDSVVPCF	9l7_NM_00116669	0.2770470	2495.4	0.9085	WB	NM_001166691	c.A866T	p.D289V	protein-altering	PVNLLNSPDCDVKTVDSVVPCFMKRQTSR	PVNLLNSPDCDVKTDDSVVPCFMKRQTSR	6	80721667	.	A	T	225	PASS	DP=500;VDB=4.603606e-02;RPB=1.539670e+00;AF1=0.5;AC1=1;DP4=117,139,55,80;MQ=60;FQ=225;PV4=0.62,0.0018,1,1;ACGTNacgtnPLUS=54,0,0,26,0,94,0,0,49,0;ACGTNacgtnMINUS=63,0,0,31,0,111,0,0,63,0	GT:PL:GQ	0/1:255,0,255:99	GTGAAGACAG,TGATTCAGTT	DP=122;DP5=44,77,0,0,0;DP5all=44,78,0,0,0;ACGTNacgtnHQ=44,0,0,0,0,77,0,0,0,0;ACGTNacgtn=44,0,0,0,0,78,0,0,0,0;VAF=0.00;TSR=0;PBINOM=3.76158192263134e-37	somatic	.	.	exonic	TTK	nonsynonymous SNV	TTK:ENST00000369798.2:exon8:c.A866T:p.D289V,TTK:ENST00000230510.3:exon8:c.A866T:p.D289V,TTK:ENST00000509894.1:exon8:c.A866T:p.D289V,	.	6q14.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	3
14	HLA-A*01:01	TVDSVVPCFM	TVDSVPCFM	0	4	1	0	0	TVDSVVPCFM	9l7_NM_00116669	0.2977490	1994.6	0.7749	WB	14	HLA-A*01:01	TDDSVVPCFM	TDDSVVCFM	0	6	1	0	0	TDDSVVPCFM	9l7_NM_00116669	0.1383920	11185.9	3.5703	nonB	NM_001166691	c.A866T	p.D289V	protein-altering	PVNLLNSPDCDVKTVDSVVPCFMKRQTSR	PVNLLNSPDCDVKTDDSVVPCFMKRQTSR	6	80721667	.	A	T	225	PASS	DP=500;VDB=4.603606e-02;RPB=1.539670e+00;AF1=0.5;AC1=1;DP4=117,139,55,80;MQ=60;FQ=225;PV4=0.62,0.0018,1,1;ACGTNacgtnPLUS=54,0,0,26,0,94,0,0,49,0;ACGTNacgtnMINUS=63,0,0,31,0,111,0,0,63,0	GT:PL:GQ	0/1:255,0,255:99	GTGAAGACAG,TGATTCAGTT	DP=122;DP5=44,77,0,0,0;DP5all=44,78,0,0,0;ACGTNacgtnHQ=44,0,0,0,0,77,0,0,0,0;ACGTNacgtn=44,0,0,0,0,78,0,0,0,0;VAF=0.00;TSR=0;PBINOM=3.76158192263134e-37	somatic	.	.	exonic	TTK	nonsynonymous SNV	TTK:ENST00000369798.2:exon8:c.A866T:p.D289V,TTK:ENST00000230510.3:exon8:c.A866T:p.D289V,TTK:ENST00000509894.1:exon8:c.A866T:p.D289V,	.	6q14.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	2
14	HLA-A*01:01	TVDSVVPCF	TVDSVVPCF	0	0	0	0	0	TVDSVVPCF	9l7_NM_00116669	0.2659750	2812.9	0.9919	WB	14	HLA-A*01:01	TDDSVVPCF	TDDSVVPCF	0	0	0	0	0	TDDSVVPCF	9l7_NM_00116669	0.1141990	14532.9	5.0875	nonB	NM_001166691	c.A866T	p.D289V	protein-altering	PVNLLNSPDCDVKTVDSVVPCFMKRQTSR	PVNLLNSPDCDVKTDDSVVPCFMKRQTSR	6	80721667	.	A	T	225	PASS	DP=500;VDB=4.603606e-02;RPB=1.539670e+00;AF1=0.5;AC1=1;DP4=117,139,55,80;MQ=60;FQ=225;PV4=0.62,0.0018,1,1;ACGTNacgtnPLUS=54,0,0,26,0,94,0,0,49,0;ACGTNacgtnMINUS=63,0,0,31,0,111,0,0,63,0	GT:PL:GQ	0/1:255,0,255:99	GTGAAGACAG,TGATTCAGTT	DP=122;DP5=44,77,0,0,0;DP5all=44,78,0,0,0;ACGTNacgtnHQ=44,0,0,0,0,77,0,0,0,0;ACGTNacgtn=44,0,0,0,0,78,0,0,0,0;VAF=0.00;TSR=0;PBINOM=3.76158192263134e-37	somatic	.	.	exonic	TTK	nonsynonymous SNV	TTK:ENST00000369798.2:exon8:c.A866T:p.D289V,TTK:ENST00000230510.3:exon8:c.A866T:p.D289V,TTK:ENST00000509894.1:exon8:c.A866T:p.D289V,	.	6q14.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	2
11	HLA-A*01:01	LSLPWGWLH	LSLPWGWLH	0	0	0	0	0	LSLPWGWLH	13l11_NM_016582	0.2338000	3984.3	1.2777	WB	11	HLA-A*01:01	LSLPGGWLH	LSLPGGWLH	0	0	0	0	0	LSLPGGWLH	13l11_NM_016582	0.1848990	6762.9	2.0328	nonB	NM_016582	c.G1561T	p.G521W	protein-altering	SLLGSSLVALLSLPWGWLHCPKDFGNINN	SLLGSSLVALLSLPGGWLHCPKDFGNINN	11	60705372	.	C	A	-0	PASS	DP=211;VDB=7.747402e-04;RPB=-1.940059e+00;AF1=0;AC1=0;DP4=122,39,6,2;MQ=60;FQ=-282;PV4=1,0.24,1,0.042;ACGTNacgtnPLUS=4,56,0,0,0,3,37,0,0,0;ACGTNacgtnMINUS=2,65,0,0,0,1,38,0,0,0	GT:PL:GQ	0/0:0,255,255:99	AGCCAGCCCC,GGGCAAGGAC	DP=250;DP5=167,79,0,0,0;DP5all=168,82,0,0,0;ACGTNacgtnHQ=0,167,0,0,0,0,79,0,0,0;ACGTNacgtn=0,168,0,0,0,0,82,0,0,0;VAF=0.00;TSR=0;PBINOM=8.84343660041662e-75	somatic	.	.	exonic	SLC15A3	nonsynonymous SNV	SLC15A3:ENST00000227880.3:exon7:c.G1561T:p.G521W,SLC15A3:ENST00000536784.1:exon1:c.G85T:p.G29W,	.	11q12.2	.	.	.	.	74;normScore=42.2	1	.	10	somatic	.	0	0	0	0	.	.	.	4	.	.	.	.	.	.	POLR2A	5
12	HLA-A*01:01	CPMCGSRFGY	CMCGSRFGY	0	1	1	0	0	CPMCGSRFGY	18l16_NM_031885	0.2106490	5118.4	1.5639	WB	12	HLA-A*01:01	CPMYGSRFGY	CMYGSRFGY	0	1	1	0	0	CPMYGSRFGY	18l16_NM_031885	0.2243300	4414.2	1.3813	WB	NM_031885	c.A638G	p.Y213C	protein-altering	EMTETEIVTSLCPMCGSRFGYALSNGTVG	EMTETEIVTSLCPMYGSRFGYALSNGTVG	16	56540111	.	T	C	225	PASS	DP=290;VDB=1.037988e-01;RPB=2.896480e-01;AF1=0.5;AC1=1;DP4=66,51,69,40;MQ=60;FQ=225;PV4=0.72,1,1,1;ACGTNacgtnPLUS=0,36,0,34,0,0,43,0,33,0;ACGTNacgtnMINUS=0,33,0,31,0,0,31,0,44,0	GT:PL:GQ	0/1:255,0,255:99	TCGACTGCCA,ACATGGGACA	DP=126;DP5=50,76,0,0,0;DP5all=50,76,0,0,0;ACGTNacgtnHQ=0,0,0,50,0,0,0,0,76,0;ACGTNacgtn=0,0,0,50,0,0,0,0,76,0;VAF=0.00;TSR=0;PBINOM=1.1754943508223e-38	somatic	.	.	exonic	BBS2	nonsynonymous SNV	BBS2:ENST00000562012.1:exon2:c.A59G:p.Y20C,BBS2:ENST00000568104.1:exon6:c.A638G:p.Y213C,BBS2:ENST00000245157.5:exon6:c.A638G:p.Y213C,	.	16q12.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1783944;score=649	.	4
10	HLA-A*01:01	LLHPIPSIEY	LLHPISIEY	0	5	1	0	0	LLHPIPSIEY	24l18_NM_199242	0.2378500	3813.5	1.2363	WB	10	HLA-A*01:01	LLHPITSIEY	LLHPITSEY	0	7	1	0	0	LLHPITSIEY	24l18_NM_199242	0.2592940	3023.8	1.0450	WB	NM_199242	c.A1126C	p.T376P	protein-altering	QSLEFPSSCLLHPIPSIEYQWIQGRLKAE	QSLEFPSSCLLHPITSIEYQWIQGRLKAE	17	73832929	.	T	G	-0	PASS	DP=168;VDB=1.486825e-03;RPB=-3.694597e+00;AF1=0;AC1=0;DP4=68,55,3,4;MQ=59;FQ=-223;PV4=0.51,1,1.1e-30,1.5e-07;ACGTNacgtnPLUS=0,0,3,35,0,0,0,7,42,0;ACGTNacgtnMINUS=0,0,0,31,0,0,0,0,40,0	GT:PL:GQ	0/0:0,196,255:99	TCGATGCTGG,GATGGGGTGC	DP=143;DP5=53,87,0,0,0;DP5all=55,88,0,0,0;ACGTNacgtnHQ=0,0,0,53,0,0,0,0,87,0;ACGTNacgtn=0,0,0,55,0,0,0,0,88,0;VAF=0.00;TSR=0;PBINOM=7.17464813734314e-43	somatic	.	.	exonic	UNC13D	nonsynonymous SNV	UNC13D:ENST00000412096.2:exon13:c.A1126C:p.T376P,UNC13D:ENST00000207549.4:exon13:c.A1126C:p.T376P,	.	17q25.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	9	.	.	.	.	.	PCS_2038706;score=618	.	6
13	HLA-A*01:01	QHAASGLWLTY	QASGLWLTY	0	1	2	0	0	QHAASGLWLTY	28l22_NM_000540	0.2090850	5205.8	1.5849	WB	13	HLA-A*01:01	QHVASGLWLTY	QASGLWLTY	0	1	2	0	0	QHVASGLWLTY	28l22_NM_000540	0.2120180	5043.2	1.5455	WB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	3
14	HLA-A*01:01	HAASGLWLTY	HAASGLWLY	0	8	1	0	0	HAASGLWLTY	28l22_NM_000540	0.3798980	820.1	0.4185	SB	14	HLA-A*01:01	HVASGLWLTY	HVASGLWLY	0	8	1	0	0	HVASGLWLTY	28l22_NM_000540	0.3789320	828.7	0.4217	SB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	2
15	HLA-A*01:01	AASGLWLTY	AASGLWLTY	0	0	0	0	0	AASGLWLTY	28l22_NM_000540	0.3405820	1254.8	0.5621	WB	15	HLA-A*01:01	VASGLWLTY	VASGLWLTY	0	0	0	0	0	VASGLWLTY	28l22_NM_000540	0.3663430	949.6	0.4637	SB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	1
12	HLA-A*02:01	FVQPSLGFV	FVQPSLGFV	0	0	0	0	0	FVQPSLGFV	5l5_NM_00100841	0.7013930	25.3	0.3463	SB	12	HLA-A*02:01	FVQSSLGFV	FVQSSLGFV	0	0	0	0	0	FVQSSLGFV	5l5_NM_00100841	0.6822130	31.1	0.4165	SB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	4
12	HLA-A*02:01	KTVPASVFSV	KTVASVFSV	0	3	1	0	0	KTVPASVFSV	12l10_NM_138421	0.5002410	223.0	1.7620	WB	12	HLA-A*02:01	KTVLASVFSV	KVLASVFSV	0	1	1	0	0	KTVLASVFSV	12l10_NM_138421	0.6549980	41.8	0.5408	WB	NM_138421	c.T968C	p.L323P	protein-altering	SDDPPIILQEQKTVPASVFSVLSAIYASQ	SDDPPIILQEQKTVLASVFSVLSAIYASQ	11	18108487	.	A	G	225	PASS	DP=416;VDB=2.454252e-01;RPB=7.889910e-01;AF1=0.5;AC1=1;DP4=140,69,73,33;MQ=60;FQ=225;PV4=1,0.22,1,1;ACGTNacgtnPLUS=67,0,43,0,0,69,0,43,0,0;ACGTNacgtnMINUS=72,0,31,0,0,59,0,25,0,0	GT:PL:GQ	0/1:255,0,255:99	AACAGAGGCT,GCACTGTTTT	DP=180;DP5=92,84,0,0,0;DP5all=94,86,0,0,0;ACGTNacgtnHQ=92,0,0,0,0,84,0,0,0,0;ACGTNacgtn=94,0,0,0,0,86,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.04404871487976e-53	somatic	.	.	exonic	SAAL1	nonsynonymous SNV	SAAL1:ENST00000531751.1:exon6:c.T635C:p.L212P,SAAL1:ENST00000531581.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000529318.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000300013.4:exon9:c.T968C:p.L323P,SAAL1:ENST00000524803.1:exon9:c.T968C:p.L323P,	.	11p15.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_742229;score=516	.	4
13	HLA-A*02:01	TVPASVFSV	TVPASVFSV	0	0	0	0	0	TVPASVFSV	12l10_NM_138421	0.5880680	86.2	0.9596	WB	13	HLA-A*02:01	TVLASVFSV	TVLASVFSV	0	0	0	0	0	TVLASVFSV	12l10_NM_138421	0.7728800	11.7	0.1396	SB	NM_138421	c.T968C	p.L323P	protein-altering	SDDPPIILQEQKTVPASVFSVLSAIYASQ	SDDPPIILQEQKTVLASVFSVLSAIYASQ	11	18108487	.	A	G	225	PASS	DP=416;VDB=2.454252e-01;RPB=7.889910e-01;AF1=0.5;AC1=1;DP4=140,69,73,33;MQ=60;FQ=225;PV4=1,0.22,1,1;ACGTNacgtnPLUS=67,0,43,0,0,69,0,43,0,0;ACGTNacgtnMINUS=72,0,31,0,0,59,0,25,0,0	GT:PL:GQ	0/1:255,0,255:99	AACAGAGGCT,GCACTGTTTT	DP=180;DP5=92,84,0,0,0;DP5all=94,86,0,0,0;ACGTNacgtnHQ=92,0,0,0,0,84,0,0,0,0;ACGTNacgtn=94,0,0,0,0,86,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.04404871487976e-53	somatic	.	.	exonic	SAAL1	nonsynonymous SNV	SAAL1:ENST00000531751.1:exon6:c.T635C:p.L212P,SAAL1:ENST00000531581.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000529318.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000300013.4:exon9:c.T968C:p.L323P,SAAL1:ENST00000524803.1:exon9:c.T968C:p.L323P,	.	11p15.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_742229;score=516	.	3
9	HLA-A*02:01	ALLSLPWGWL	ALLSLPWGL	0	8	1	0	0	ALLSLPWGWL	13l11_NM_016582	0.7081870	23.5	0.3226	SB	9	HLA-A*02:01	ALLSLPGGWL	ALLSLPGWL	0	6	1	0	0	ALLSLPGGWL	13l11_NM_016582	0.3766450	849.4	3.7379	nonB	NM_016582	c.G1561T	p.G521W	protein-altering	SLLGSSLVALLSLPWGWLHCPKDFGNINN	SLLGSSLVALLSLPGGWLHCPKDFGNINN	11	60705372	.	C	A	-0	PASS	DP=211;VDB=7.747402e-04;RPB=-1.940059e+00;AF1=0;AC1=0;DP4=122,39,6,2;MQ=60;FQ=-282;PV4=1,0.24,1,0.042;ACGTNacgtnPLUS=4,56,0,0,0,3,37,0,0,0;ACGTNacgtnMINUS=2,65,0,0,0,1,38,0,0,0	GT:PL:GQ	0/0:0,255,255:99	AGCCAGCCCC,GGGCAAGGAC	DP=250;DP5=167,79,0,0,0;DP5all=168,82,0,0,0;ACGTNacgtnHQ=0,167,0,0,0,0,79,0,0,0;ACGTNacgtn=0,168,0,0,0,0,82,0,0,0;VAF=0.00;TSR=0;PBINOM=8.84343660041662e-75	somatic	.	.	exonic	SLC15A3	nonsynonymous SNV	SLC15A3:ENST00000227880.3:exon7:c.G1561T:p.G521W,SLC15A3:ENST00000536784.1:exon1:c.G85T:p.G29W,	.	11q12.2	.	.	.	.	74;normScore=42.2	1	.	10	somatic	.	0	0	0	0	.	.	.	4	.	.	.	.	.	.	POLR2A	7
10	HLA-A*02:01	LFMNSILISGV	FMNSILISV	1	8	1	0	0	FMNSILISGV	14l12_NM_013381	0.5881340	86.2	0.9591	WB	10	HLA-A*02:01	LFMNSKLISGV	FMNSKLISV	1	8	1	0	0	FMNSKLISGV	14l12_NM_013381	0.4880980	254.3	1.9202	WB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	6
11	HLA-A*02:01	FMNSILISGVT	FMNSILISV	0	8	1	0	0	FMNSILISGV	14l12_NM_013381	0.5313770	159.2	1.4338	WB	11	HLA-A*02:01	FMNSKLISGVT	FMNSKLISV	0	8	1	0	0	FMNSKLISGV	14l12_NM_013381	0.4214080	523.3	2.8863	nonB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	5
11	HLA-A*02:01	FMNSILISGV	FMNSILIGV	0	7	1	0	0	FMNSILISGV	14l12_NM_013381	0.8428200	5.5	0.0427	SB	11	HLA-A*02:01	FMNSKLISGV	FMNSKLISV	0	8	1	0	0	FMNSKLISGV	14l12_NM_013381	0.8049190	8.3	0.0883	SB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	5
15	HLA-A*02:01	ILISGVTEFL	ILISGVTFL	0	7	1	0	0	ILISGVTEFL	14l12_NM_013381	0.6957040	26.9	0.3662	SB	15	HLA-A*02:01	KLISGVTEFL	KLISGVTFL	0	7	1	0	0	KLISGVTEFL	14l12_NM_013381	0.6858170	29.9	0.4009	SB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	1
9	HLA-A*02:01	ALFMNSILI	ALFMNSILI	0	0	0	0	0	ALFMNSILI	14l12_NM_013381	0.6457480	46.2	0.5886	WB	9	HLA-A*02:01	ALFMNSKLI	ALFMNSKLI	0	0	0	0	0	ALFMNSKLI	14l12_NM_013381	0.3736080	877.8	3.8000	nonB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	7
8	HLA-A*02:01	SCLLHPIPSI	SLLHPIPSI	0	1	1	0	0	SCLLHPIPSI	24l18_NM_199242	0.5674890	107.7	1.1076	WB	8	HLA-A*02:01	SCLLHPITSI	SLLHPITSI	0	1	1	0	0	SCLLHPITSI	24l18_NM_199242	0.4842150	265.3	1.9692	WB	NM_199242	c.A1126C	p.T376P	protein-altering	QSLEFPSSCLLHPIPSIEYQWIQGRLKAE	QSLEFPSSCLLHPITSIEYQWIQGRLKAE	17	73832929	.	T	G	-0	PASS	DP=168;VDB=1.486825e-03;RPB=-3.694597e+00;AF1=0;AC1=0;DP4=68,55,3,4;MQ=59;FQ=-223;PV4=0.51,1,1.1e-30,1.5e-07;ACGTNacgtnPLUS=0,0,3,35,0,0,0,7,42,0;ACGTNacgtnMINUS=0,0,0,31,0,0,0,0,40,0	GT:PL:GQ	0/0:0,196,255:99	TCGATGCTGG,GATGGGGTGC	DP=143;DP5=53,87,0,0,0;DP5all=55,88,0,0,0;ACGTNacgtnHQ=0,0,0,53,0,0,0,0,87,0;ACGTNacgtn=0,0,0,55,0,0,0,0,88,0;VAF=0.00;TSR=0;PBINOM=7.17464813734314e-43	somatic	.	.	exonic	UNC13D	nonsynonymous SNV	UNC13D:ENST00000412096.2:exon13:c.A1126C:p.T376P,UNC13D:ENST00000207549.4:exon13:c.A1126C:p.T376P,	.	17q25.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	9	.	.	.	.	.	PCS_2038706;score=618	.	8
9	HLA-A*02:01	CLLHPIPSI	CLLHPIPSI	0	0	0	0	0	CLLHPIPSI	24l18_NM_199242	0.6939390	27.4	0.3724	SB	9	HLA-A*02:01	CLLHPITSI	CLLHPITSI	0	0	0	0	0	CLLHPITSI	24l18_NM_199242	0.6048160	71.9	0.8438	WB	NM_199242	c.A1126C	p.T376P	protein-altering	QSLEFPSSCLLHPIPSIEYQWIQGRLKAE	QSLEFPSSCLLHPITSIEYQWIQGRLKAE	17	73832929	.	T	G	-0	PASS	DP=168;VDB=1.486825e-03;RPB=-3.694597e+00;AF1=0;AC1=0;DP4=68,55,3,4;MQ=59;FQ=-223;PV4=0.51,1,1.1e-30,1.5e-07;ACGTNacgtnPLUS=0,0,3,35,0,0,0,7,42,0;ACGTNacgtnMINUS=0,0,0,31,0,0,0,0,40,0	GT:PL:GQ	0/0:0,196,255:99	TCGATGCTGG,GATGGGGTGC	DP=143;DP5=53,87,0,0,0;DP5all=55,88,0,0,0;ACGTNacgtnHQ=0,0,0,53,0,0,0,0,87,0;ACGTNacgtn=0,0,0,55,0,0,0,0,88,0;VAF=0.00;TSR=0;PBINOM=7.17464813734314e-43	somatic	.	.	exonic	UNC13D	nonsynonymous SNV	UNC13D:ENST00000412096.2:exon13:c.A1126C:p.T376P,UNC13D:ENST00000207549.4:exon13:c.A1126C:p.T376P,	.	17q25.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	9	.	.	.	.	.	PCS_2038706;score=618	.	7
2	HLA-A*02:01	YRLQWLLPVL	YLQWLLPVL	0	1	1	0	0	YRLQWLLPVL	31l25_NM_001167	0.6307360	54.3	0.6746	WB	2	HLA-A*02:01	YCLQWLLPVL	YLQWLLPVL	0	1	1	0	0	YCLQWLLPVL	31l25_NM_001167	0.6304420	54.5	0.6763	WB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	2
3	HLA-A*02:01	RLQWLLPVLL	RLWLLPVLL	0	2	1	0	0	RLQWLLPVLL	31l25_NM_001167	0.6296330	55.0	0.6810	WB	3	HLA-A*02:01	CLQWLLPVLL	CLQWLLPLL	0	7	1	0	0	CLQWLLPVLL	31l25_NM_001167	0.4601590	344.1	2.2957	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	1
3	HLA-A*02:01	RLQWLLPVL	RLQWLLPVL	0	0	0	0	0	RLQWLLPVL	31l25_NM_001167	0.6531470	42.6	0.5504	WB	3	HLA-A*02:01	CLQWLLPVL	CLQWLLPVL	0	0	0	0	0	CLQWLLPVL	31l25_NM_001167	0.5429110	140.6	1.3188	WB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	1
3	HLA-A*02:01	RLQWLLPV	RL-QWLLPV	0	0	0	2	1	RLQWLLPV	31l25_NM_001167	0.5140400	192.1	1.6033	WB	3	HLA-A*02:01	CLQWLLPV	CL-QWLLPV	0	0	0	2	1	CLQWLLPV	31l25_NM_001167	0.3864040	764.3	3.5385	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	1
6	HLA-B*08:01	RMASHTGRL	RMASHTGRL	0	0	0	0	0	RMASHTGRL	4l4_NM_00100469	0.3933640	708.9	1.0084	WB	6	HLA-B*08:01	RMANHTGRL	RMANHTGRL	0	0	0	0	0	RMANHTGRL	4l4_NM_00100469	0.3872600	757.3	1.0650	WB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	4
14	HLA-B*08:01	QPSLGFVAL	QPSLGFVAL	0	0	0	0	0	QPSLGFVAL	5l5_NM_00100841	0.3285800	1428.8	1.7692	WB	14	HLA-B*08:01	QSSLGFVAL	QSSLGFVAL	0	0	0	0	0	QSSLGFVAL	5l5_NM_00100841	0.2131550	4981.5	5.4227	nonB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	2
14	HLA-B*08:01	VPASVFSVL	VPASVFSVL	0	0	0	0	0	VPASVFSVL	12l10_NM_138421	0.3630770	983.7	1.3152	WB	14	HLA-B*08:01	VLASVFSVL	VLASVFSVL	0	0	0	0	0	VLASVFSVL	12l10_NM_138421	0.3807800	812.3	1.1289	WB	NM_138421	c.T968C	p.L323P	protein-altering	SDDPPIILQEQKTVPASVFSVLSAIYASQ	SDDPPIILQEQKTVLASVFSVLSAIYASQ	11	18108487	.	A	G	225	PASS	DP=416;VDB=2.454252e-01;RPB=7.889910e-01;AF1=0.5;AC1=1;DP4=140,69,73,33;MQ=60;FQ=225;PV4=1,0.22,1,1;ACGTNacgtnPLUS=67,0,43,0,0,69,0,43,0,0;ACGTNacgtnMINUS=72,0,31,0,0,59,0,25,0,0	GT:PL:GQ	0/1:255,0,255:99	AACAGAGGCT,GCACTGTTTT	DP=180;DP5=92,84,0,0,0;DP5all=94,86,0,0,0;ACGTNacgtnHQ=92,0,0,0,0,84,0,0,0,0;ACGTNacgtn=94,0,0,0,0,86,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.04404871487976e-53	somatic	.	.	exonic	SAAL1	nonsynonymous SNV	SAAL1:ENST00000531751.1:exon6:c.T635C:p.L212P,SAAL1:ENST00000531581.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000529318.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000300013.4:exon9:c.T968C:p.L323P,SAAL1:ENST00000524803.1:exon9:c.T968C:p.L323P,	.	11p15.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_742229;score=516	.	2
12	HLA-B*08:01	RARVKNQVTQL	RARVKVTQL	0	5	2	0	0	RARVKNQVTQL	16l14_NM_005956	0.3525040	1103.0	1.4302	WB	12	HLA-B*08:01	RARLKNQVTQL	RARLKVTQL	0	5	2	0	0	RARLKNQVTQL	16l14_NM_005956	0.3700900	911.9	1.2421	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	4
12	HLA-B*08:01	RARVKNQVT	RARVKNQVT	0	0	0	0	0	RARVKNQVT	16l14_NM_005956	0.3381690	1288.0	1.6316	WB	12	HLA-B*08:01	RARLKNQVT	RARLKNQVT	0	0	0	0	0	RARLKNQVT	16l14_NM_005956	0.3562570	1059.1	1.3860	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	4
14	HLA-B*08:01	RVKNQVTQL	RVKNQVTQL	0	0	0	0	0	RVKNQVTQL	16l14_NM_005956	0.4030020	638.7	0.9258	WB	14	HLA-B*08:01	RLKNQVTQL	RLKNQVTQL	0	0	0	0	0	RLKNQVTQL	16l14_NM_005956	0.4932400	240.6	0.4192	SB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	2
8	HLA-B*08:01	SAQIRARV	SAQIRA-RV	0	0	0	6	1	SAQIRARV	16l14_NM_005956	0.3563760	1057.7	1.3847	WB	8	HLA-B*08:01	SAQIRARL	SAQIRA-RL	0	0	0	6	1	SAQIRARL	16l14_NM_005956	0.5172070	185.6	0.3292	SB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	8
12	HLA-B*08:01	RARVKNQV	RARVKN-QV	0	0	0	6	1	RARVKNQV	16l14_NM_005956	0.4015120	649.0	0.9384	WB	12	HLA-B*08:01	RARLKNQV	RARLKN-QV	0	0	0	6	1	RARLKNQV	16l14_NM_005956	0.4283340	485.6	0.7490	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	4
14	HLA-B*08:01	CVKAKSQPHF	CVKAKSQPF	0	8	1	0	0	CVKAKSQPHF	17l15_NM_001242	0.4166270	551.1	0.8271	WB	14	HLA-B*08:01	CAKAKSQPHF	CAKAKSQPF	0	8	1	0	0	CAKAKSQPHF	17l15_NM_001242	0.4349780	451.9	0.7054	WB	NM_001242786	c.C1058T	p.A353V	protein-altering	DLEIDRRDLSMPRCVKAKSQPHFPVLAQY	DLEIDRRDLSMPRCAKAKSQPHFPVLAQY	14	105685610	.	G	A	225	PASS	DP=197;VDB=5.232184e-05;RPB=5.656900e-01;AF1=0.5;AC1=1;DP4=48,54,27,19;MQ=60;FQ=225;PV4=0.34,0.15,1,1;ACGTNacgtnPLUS=11,0,24,0,0,14,0,36,0,0;ACGTNacgtnMINUS=18,0,24,0,0,22,0,46,0,0	GT:PL:GQ	0/1:255,0,255:99	TTTAGCCTTC,CACACCGGGG	DP=158;DP5=66,90,0,0,0;DP5all=68,90,0,0,0;ACGTNacgtnHQ=0,0,66,0,0,0,0,90,0,0;ACGTNacgtn=0,0,68,0,0,0,0,90,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	BRF1	nonsynonymous SNV	BRF1:ENST00000440513.3:exon13:c.C1058T:p.A353V,	.	14q32.33	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_18818	.	.	.	.	.	.	CGI(29%);score=71	.	NR3C1	2
9	HLA-B*08:01	LSMPRCVKA	LSMPRCVKA	0	0	0	0	0	LSMPRCVKA	17l15_NM_001242	0.3263270	1464.1	1.8019	WB	9	HLA-B*08:01	LSMPRCAKA	LSMPRCAKA	0	0	0	0	0	LSMPRCAKA	17l15_NM_001242	0.3429260	1223.4	1.5613	WB	NM_001242786	c.C1058T	p.A353V	protein-altering	DLEIDRRDLSMPRCVKAKSQPHFPVLAQY	DLEIDRRDLSMPRCAKAKSQPHFPVLAQY	14	105685610	.	G	A	225	PASS	DP=197;VDB=5.232184e-05;RPB=5.656900e-01;AF1=0.5;AC1=1;DP4=48,54,27,19;MQ=60;FQ=225;PV4=0.34,0.15,1,1;ACGTNacgtnPLUS=11,0,24,0,0,14,0,36,0,0;ACGTNacgtnMINUS=18,0,24,0,0,22,0,46,0,0	GT:PL:GQ	0/1:255,0,255:99	TTTAGCCTTC,CACACCGGGG	DP=158;DP5=66,90,0,0,0;DP5all=68,90,0,0,0;ACGTNacgtnHQ=0,0,66,0,0,0,0,90,0,0;ACGTNacgtn=0,0,68,0,0,0,0,90,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	BRF1	nonsynonymous SNV	BRF1:ENST00000440513.3:exon13:c.C1058T:p.A353V,	.	14q32.33	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_18818	.	.	.	.	.	.	CGI(29%);score=71	.	NR3C1	7
14	HLA-B*08:01	MCGSRFGYAL	MCGSRFYAL	0	6	1	0	0	MCGSRFGYAL	18l16_NM_031885	0.4825180	270.2	0.4613	SB	14	HLA-B*08:01	MYGSRFGYAL	MYGSRFYAL	0	6	1	0	0	MYGSRFGYAL	18l16_NM_031885	0.5060470	209.4	0.3706	SB	NM_031885	c.A638G	p.Y213C	protein-altering	EMTETEIVTSLCPMCGSRFGYALSNGTVG	EMTETEIVTSLCPMYGSRFGYALSNGTVG	16	56540111	.	T	C	225	PASS	DP=290;VDB=1.037988e-01;RPB=2.896480e-01;AF1=0.5;AC1=1;DP4=66,51,69,40;MQ=60;FQ=225;PV4=0.72,1,1,1;ACGTNacgtnPLUS=0,36,0,34,0,0,43,0,33,0;ACGTNacgtnMINUS=0,33,0,31,0,0,31,0,44,0	GT:PL:GQ	0/1:255,0,255:99	TCGACTGCCA,ACATGGGACA	DP=126;DP5=50,76,0,0,0;DP5all=50,76,0,0,0;ACGTNacgtnHQ=0,0,0,50,0,0,0,0,76,0;ACGTNacgtn=0,0,0,50,0,0,0,0,76,0;VAF=0.00;TSR=0;PBINOM=1.1754943508223e-38	somatic	.	.	exonic	BBS2	nonsynonymous SNV	BBS2:ENST00000562012.1:exon2:c.A59G:p.Y20C,BBS2:ENST00000568104.1:exon6:c.A638G:p.Y213C,BBS2:ENST00000245157.5:exon6:c.A638G:p.Y213C,	.	16q12.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1783944;score=649	.	2
15	HLA-B*08:01	CGSRFGYAL	CGSRFGYAL	0	0	0	0	0	CGSRFGYAL	18l16_NM_031885	0.3383340	1285.7	1.6292	WB	15	HLA-B*08:01	YGSRFGYAL	YGSRFGYAL	0	0	0	0	0	YGSRFGYAL	18l16_NM_031885	0.4158940	555.5	0.8321	WB	NM_031885	c.A638G	p.Y213C	protein-altering	EMTETEIVTSLCPMCGSRFGYALSNGTVG	EMTETEIVTSLCPMYGSRFGYALSNGTVG	16	56540111	.	T	C	225	PASS	DP=290;VDB=1.037988e-01;RPB=2.896480e-01;AF1=0.5;AC1=1;DP4=66,51,69,40;MQ=60;FQ=225;PV4=0.72,1,1,1;ACGTNacgtnPLUS=0,36,0,34,0,0,43,0,33,0;ACGTNacgtnMINUS=0,33,0,31,0,0,31,0,44,0	GT:PL:GQ	0/1:255,0,255:99	TCGACTGCCA,ACATGGGACA	DP=126;DP5=50,76,0,0,0;DP5all=50,76,0,0,0;ACGTNacgtnHQ=0,0,0,50,0,0,0,0,76,0;ACGTNacgtn=0,0,0,50,0,0,0,0,76,0;VAF=0.00;TSR=0;PBINOM=1.1754943508223e-38	somatic	.	.	exonic	BBS2	nonsynonymous SNV	BBS2:ENST00000562012.1:exon2:c.A59G:p.Y20C,BBS2:ENST00000568104.1:exon6:c.A638G:p.Y213C,BBS2:ENST00000245157.5:exon6:c.A638G:p.Y213C,	.	16q12.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1783944;score=649	.	1
6	HLA-B*08:01	LPKNGSYRPF	LPKNSYRPF	0	4	1	0	0	LPKNGSYRPF	19l17_NM_001135	0.3624690	990.2	1.3215	WB	6	HLA-B*08:01	LPKNGSYRPS	LPKNGSYPS	0	7	1	0	0	LPKNGSYRPS	19l17_NM_001135	0.1436450	10567.8	11.7603	nonB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	10
1	HLA-B*08:01	MYRLQWLLPV	MYRLQLLPV	0	5	1	0	0	MYRLQWLLPV	31l25_NM_001167	0.3276410	1443.4	1.7827	WB	1	HLA-B*08:01	MYCLQWLLPV	MYLQWLLPV	0	2	1	0	0	MYCLQWLLPV	31l25_NM_001167	0.1492450	9946.5	10.9734	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	3
1	HLA-B*08:01	MYRLQWLL	MYRLQW-LL	0	0	0	6	1	MYRLQWLL	31l25_NM_001167	0.3756270	858.8	1.1839	WB	1	HLA-B*08:01	MYCLQWLL	-MYCLQWLL	0	0	0	0	1	MYCLQWLL	31l25_NM_001167	0.1951420	6053.5	6.5523	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	3
8	HLA-B*08:01	YLNYRIHAS	YLNYRIHAS	0	0	0	0	0	YLNYRIHAS	38l26_NM_181622	0.4857250	261.0	0.4487	SB	8	HLA-B*08:01	YLNYRIHTS	YLNYRIHTS	0	0	0	0	0	YLNYRIHTS	38l26_NM_181622	0.4228780	515.1	0.7848	WB	NM_181622	c.A406G	p.T136A	protein-altering	CGSNGFRYLNYRIHASPSQSYRSRFCHPI	CGSNGFRYLNYRIHTSPSQSYRSRFCHPI	21	31797825	.	T	C	-0	PASS	DP=418;VDB=2.085269e-02;RPB=-1.564543e+00;AF1=0;AC1=0;DP4=198,123,14,3;MQ=60;FQ=-282;PV4=0.53,1,3.6e-13,1;ACGTNacgtnPLUS=0,11,0,77,0,0,5,0,77,0;ACGTNacgtnMINUS=0,3,0,121,0,0,5,0,112,0	GT:PL:GQ	0/0:0,255,255:99	GAAGGGGAGG,ATGGATTCTA	DP=209;DP5=97,104,0,0,0;DP5all=102,107,0,0,0;ACGTNacgtnHQ=0,0,0,97,0,0,0,0,104,0;ACGTNacgtn=0,0,0,102,0,0,0,0,107,0;VAF=0.00;TSR=0;PBINOM=3.11150763893051e-61	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.A406G:p.T136A,	.	21q22.11	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	8
8	HLA-B*08:01	YLNYRIHA	YLNYRIH-A	0	0	0	7	1	YLNYRIHA	38l26_NM_181622	0.4259330	498.3	0.7648	WB	8	HLA-B*08:01	YLNYRIHT	YLNYRIHT-	0	0	0	8	1	YLNYRIHT	38l26_NM_181622	0.3215310	1542.1	1.8881	WB	NM_181622	c.A406G	p.T136A	protein-altering	CGSNGFRYLNYRIHASPSQSYRSRFCHPI	CGSNGFRYLNYRIHTSPSQSYRSRFCHPI	21	31797825	.	T	C	-0	PASS	DP=418;VDB=2.085269e-02;RPB=-1.564543e+00;AF1=0;AC1=0;DP4=198,123,14,3;MQ=60;FQ=-282;PV4=0.53,1,3.6e-13,1;ACGTNacgtnPLUS=0,11,0,77,0,0,5,0,77,0;ACGTNacgtnMINUS=0,3,0,121,0,0,5,0,112,0	GT:PL:GQ	0/0:0,255,255:99	GAAGGGGAGG,ATGGATTCTA	DP=209;DP5=97,104,0,0,0;DP5all=102,107,0,0,0;ACGTNacgtnHQ=0,0,0,97,0,0,0,0,104,0;ACGTNacgtn=0,0,0,102,0,0,0,0,107,0;VAF=0.00;TSR=0;PBINOM=3.11150763893051e-61	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.A406G:p.T136A,	.	21q22.11	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	8
11	HLA-B*08:01	YLNYKIHTS	YLNYKIHTS	0	0	0	0	0	YLNYKIHTS	39l27_NM_181622	0.3425270	1228.7	1.5673	WB	11	HLA-B*08:01	YLNYRIHTS	YLNYRIHTS	0	0	0	0	0	YLNYRIHTS	39l27_NM_181622	0.4228780	515.1	0.7848	WB	NM_181622	c.G398A	p.R133K	protein-altering	SLGCGSNGFRYLNYKIHTSPSQSYRSRFC	SLGCGSNGFRYLNYRIHTSPSQSYRSRFC	21	31797833	.	C	T	-0	PASS	DP=426;VDB=1.985170e-02;RPB=-3.897429e-01;AF1=0;AC1=0;DP4=210,115,13,3;MQ=60;FQ=-282;PV4=1,1,2e-13,1;ACGTNacgtnPLUS=0,83,0,10,0,0,75,0,6,0;ACGTNacgtnMINUS=0,126,0,3,0,0,110,0,5,0	GT:PL:GQ	0/0:0,255,255:99	GGTATGGATT,TATAATTCAG	DP=217;DP5=97,107,0,1,0;DP5all=100,114,0,1,2;ACGTNacgtnHQ=0,97,0,0,0,0,107,0,1,0;ACGTNacgtn=0,100,0,0,0,2,114,0,1,0;VAF=0.00;TSR=1;PBINOM=4.00606608512319e-60	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.G398A:p.R133K,	.	21q22.11	.	.	.	.	.	1	.	10	LQVSIG	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
5	HLA-B*08:01	RKMVLTRAKAL	MVLTRAKAL	2	0	0	0	0	MVLTRAKAL	40l28_NM_001271	0.4049440	625.4	0.9093	WB	5	HLA-B*08:01	RKMVLTRAKAS	RKMVRAKAS	0	4	2	0	0	RKMVLTRAKAS	40l28_NM_001271	0.1042100	16191.6	19.7010	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	11
7	HLA-B*08:01	MVLTRAKALEL	MVLTRAKAL	0	8	2	0	0	MVLTRAKALEL	40l28_NM_001271	0.4766520	287.9	0.4843	SB	7	HLA-B*08:01	MVLTRAKASEL	MVLTRAKAL	0	8	2	0	0	MVLTRAKASEL	40l28_NM_001271	0.4756970	290.9	0.4881	SB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	9
6	HLA-B*08:01	KMVLTRAKAL	MVLTRAKAL	1	0	0	0	0	MVLTRAKAL	40l28_NM_001271	0.5527440	126.4	0.2261	SB	6	HLA-B*08:01	KMVLTRAKAS	KMLTRAKAS	0	2	1	0	0	KMVLTRAKAS	40l28_NM_001271	0.1506470	9796.8	10.8006	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	10
7	HLA-B*08:01	MVLTRAKALE	MVLTRAKAL	0	0	0	0	0	MVLTRAKAL	40l28_NM_001271	0.4566250	357.5	0.5769	WB	7	HLA-B*08:01	MVLTRAKASE	MVLTRKASE	0	5	1	0	0	MVLTRAKASE	40l28_NM_001271	0.1622130	8644.4	9.4712	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	9
8	HLA-B*08:01	VLTRAKALEL	VLRAKALEL	0	2	1	0	0	VLTRAKALEL	40l28_NM_001271	0.4531810	371.1	0.5934	WB	8	HLA-B*08:01	VLTRAKASEL	VLRAKASEL	0	2	1	0	0	VLTRAKASEL	40l28_NM_001271	0.4674940	317.9	0.5248	WB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	8
7	HLA-B*08:01	MVLTRAKAL	MVLTRAKAL	0	0	0	0	0	MVLTRAKAL	40l28_NM_001271	0.7642580	12.8	0.0121	SB	7	HLA-B*08:01	MVLTRAKAS	MVLTRAKAS	0	0	0	0	0	MVLTRAKAS	40l28_NM_001271	0.3346480	1338.0	1.6821	WB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	9
9	HLA-B*08:01	LTRAKALEL	LTRAKALEL	0	0	0	0	0	LTRAKALEL	40l28_NM_001271	0.5366220	150.5	0.2687	SB	9	HLA-B*08:01	LTRAKASEL	LTRAKASEL	0	0	0	0	0	LTRAKASEL	40l28_NM_001271	0.5390910	146.5	0.2620	SB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	7
8	HLA-B*08:01	VLTRAKAL	VL-TRAKAL	0	0	0	2	1	VLTRAKAL	40l28_NM_001271	0.4991890	225.6	0.3960	SB	8	HLA-B*08:01	VLTRAKAS	VL-TRAKAS	0	0	0	2	1	VLTRAKAS	40l28_NM_001271	0.1066310	15773.0	19.0122	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	8
10	HLA-B*08:01	TRAKALEL	T-RAKALEL	0	0	0	1	1	TRAKALEL	40l28_NM_001271	0.3513700	1116.6	1.4445	WB	10	HLA-B*08:01	TRAKASEL	T-RAKASEL	0	0	0	1	1	TRAKASEL	40l28_NM_001271	0.3506440	1125.4	1.4537	WB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	6
11	HLA-B*15:07	YTNVQPHSY	YTNVQPHSY	0	0	0	0	0	YTNVQPHSY	3l3_NM_00100413	0.4375700	439.4	1.0895	WB	11	HLA-B*15:07	YTNVLPHSY	YTNVLPHSY	0	0	0	0	0	YTNVLPHSY	3l3_NM_00100413	0.4850280	262.9	0.6775	WB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
6	HLA-B*15:07	RMASHTGRLDF	RMASHTLDF	0	6	2	0	0	RMASHTGRLDF	4l4_NM_00100469	0.5114820	197.5	0.5293	WB	6	HLA-B*15:07	RMANHTGRLDF	RMANHTLDF	0	6	2	0	0	RMANHTGRLDF	4l4_NM_00100469	0.4981190	228.2	0.5960	WB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	4
7	HLA-B*15:07	MASHTGRLDF	MASHTGLDF	0	6	1	0	0	MASHTGRLDF	4l4_NM_00100469	0.4476380	394.0	0.9861	WB	7	HLA-B*15:07	MANHTGRLDF	MANHTGLDF	0	6	1	0	0	MANHTGRLDF	4l4_NM_00100469	0.4586540	349.8	0.8847	WB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	3
6	HLA-B*15:07	RMASHTGRL	RMASHTGRL	0	0	0	0	0	RMASHTGRL	4l4_NM_00100469	0.5270750	166.8	0.4483	SB	6	HLA-B*15:07	RMANHTGRL	RMANHTGRL	0	0	0	0	0	RMANHTGRL	4l4_NM_00100469	0.5162770	187.5	0.5054	WB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	4
8	HLA-B*15:07	ASHTGRLDF	ASHTGRLDF	0	0	0	0	0	ASHTGRLDF	4l4_NM_00100469	0.3839690	784.7	1.7021	WB	8	HLA-B*15:07	ANHTGRLDF	ANHTGRLDF	0	0	0	0	0	ANHTGRLDF	4l4_NM_00100469	0.1918840	6270.7	8.7404	nonB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	2
10	HLA-B*15:07	FSFVQPSLGF	FSFQPSLGF	0	3	1	0	0	FSFVQPSLGF	5l5_NM_00100841	0.5280150	165.1	0.4433	SB	10	HLA-B*15:07	FSFVQSSLGF	FSFQSSLGF	0	3	1	0	0	FSFVQSSLGF	5l5_NM_00100841	0.5811050	93.0	0.2250	SB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	6
13	HLA-B*15:07	VQPSLGFVAL	VQSLGFVAL	0	2	1	0	0	VQPSLGFVAL	5l5_NM_00100841	0.3701890	910.9	1.9029	WB	13	HLA-B*15:07	VQSSLGFVAL	VQSSLFVAL	0	5	1	0	0	VQSSLGFVAL	5l5_NM_00100841	0.4603370	343.4	0.8698	WB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	3
13	HLA-B*15:07	KTVDSVVPCF	KTVDSVVPF	0	8	1	0	0	KTVDSVVPCF	9l7_NM_00116669	0.5417060	142.4	0.3753	SB	13	HLA-B*15:07	KTDDSVVPCF	KTDDSVVPF	0	8	1	0	0	KTDDSVVPCF	9l7_NM_00116669	0.1760480	7442.6	10.1718	nonB	NM_001166691	c.A866T	p.D289V	protein-altering	PVNLLNSPDCDVKTVDSVVPCFMKRQTSR	PVNLLNSPDCDVKTDDSVVPCFMKRQTSR	6	80721667	.	A	T	225	PASS	DP=500;VDB=4.603606e-02;RPB=1.539670e+00;AF1=0.5;AC1=1;DP4=117,139,55,80;MQ=60;FQ=225;PV4=0.62,0.0018,1,1;ACGTNacgtnPLUS=54,0,0,26,0,94,0,0,49,0;ACGTNacgtnMINUS=63,0,0,31,0,111,0,0,63,0	GT:PL:GQ	0/1:255,0,255:99	GTGAAGACAG,TGATTCAGTT	DP=122;DP5=44,77,0,0,0;DP5all=44,78,0,0,0;ACGTNacgtnHQ=44,0,0,0,0,77,0,0,0,0;ACGTNacgtn=44,0,0,0,0,78,0,0,0,0;VAF=0.00;TSR=0;PBINOM=3.76158192263134e-37	somatic	.	.	exonic	TTK	nonsynonymous SNV	TTK:ENST00000369798.2:exon8:c.A866T:p.D289V,TTK:ENST00000230510.3:exon8:c.A866T:p.D289V,TTK:ENST00000509894.1:exon8:c.A866T:p.D289V,	.	6q14.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	3
10	HLA-B*15:07	EQKTVPASVF	EQKTVASVF	0	5	1	0	0	EQKTVPASVF	12l10_NM_138421	0.4098260	593.2	1.3804	WB	10	HLA-B*15:07	EQKTVLASVF	EQKTVLSVF	0	6	1	0	0	EQKTVLASVF	12l10_NM_138421	0.4706300	307.3	0.7819	WB	NM_138421	c.T968C	p.L323P	protein-altering	SDDPPIILQEQKTVPASVFSVLSAIYASQ	SDDPPIILQEQKTVLASVFSVLSAIYASQ	11	18108487	.	A	G	225	PASS	DP=416;VDB=2.454252e-01;RPB=7.889910e-01;AF1=0.5;AC1=1;DP4=140,69,73,33;MQ=60;FQ=225;PV4=1,0.22,1,1;ACGTNacgtnPLUS=67,0,43,0,0,69,0,43,0,0;ACGTNacgtnMINUS=72,0,31,0,0,59,0,25,0,0	GT:PL:GQ	0/1:255,0,255:99	AACAGAGGCT,GCACTGTTTT	DP=180;DP5=92,84,0,0,0;DP5all=94,86,0,0,0;ACGTNacgtnHQ=92,0,0,0,0,84,0,0,0,0;ACGTNacgtn=94,0,0,0,0,86,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.04404871487976e-53	somatic	.	.	exonic	SAAL1	nonsynonymous SNV	SAAL1:ENST00000531751.1:exon6:c.T635C:p.L212P,SAAL1:ENST00000531581.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000529318.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000300013.4:exon9:c.T968C:p.L323P,SAAL1:ENST00000524803.1:exon9:c.T968C:p.L323P,	.	11p15.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_742229;score=516	.	6
6	HLA-B*15:07	SLVALLSLPW	SLVALSLPW	0	4	1	0	0	SLVALLSLPW	13l11_NM_016582	0.3761740	853.8	1.8065	WB	6	HLA-B*15:07	SLVALLSLPG	SLVALSLPG	0	4	1	0	0	SLVALLSLPG	13l11_NM_016582	0.2271140	4283.2	6.2626	nonB	NM_016582	c.G1561T	p.G521W	protein-altering	SLLGSSLVALLSLPWGWLHCPKDFGNINN	SLLGSSLVALLSLPGGWLHCPKDFGNINN	11	60705372	.	C	A	-0	PASS	DP=211;VDB=7.747402e-04;RPB=-1.940059e+00;AF1=0;AC1=0;DP4=122,39,6,2;MQ=60;FQ=-282;PV4=1,0.24,1,0.042;ACGTNacgtnPLUS=4,56,0,0,0,3,37,0,0,0;ACGTNacgtnMINUS=2,65,0,0,0,1,38,0,0,0	GT:PL:GQ	0/0:0,255,255:99	AGCCAGCCCC,GGGCAAGGAC	DP=250;DP5=167,79,0,0,0;DP5all=168,82,0,0,0;ACGTNacgtnHQ=0,167,0,0,0,0,79,0,0,0;ACGTNacgtn=0,168,0,0,0,0,82,0,0,0;VAF=0.00;TSR=0;PBINOM=8.84343660041662e-75	somatic	.	.	exonic	SLC15A3	nonsynonymous SNV	SLC15A3:ENST00000227880.3:exon7:c.G1561T:p.G521W,SLC15A3:ENST00000536784.1:exon1:c.G85T:p.G29W,	.	11q12.2	.	.	.	.	74;normScore=42.2	1	.	10	somatic	.	0	0	0	0	.	.	.	4	.	.	.	.	.	.	POLR2A	10
7	HLA-B*15:07	LVALLSLPW	LVALLSLPW	0	0	0	0	0	LVALLSLPW	13l11_NM_016582	0.3647100	966.5	1.9924	WB	7	HLA-B*15:07	LVALLSLPG	LVALLSLPG	0	0	0	0	0	LVALLSLPG	13l11_NM_016582	0.2607900	2975.3	4.6649	nonB	NM_016582	c.G1561T	p.G521W	protein-altering	SLLGSSLVALLSLPWGWLHCPKDFGNINN	SLLGSSLVALLSLPGGWLHCPKDFGNINN	11	60705372	.	C	A	-0	PASS	DP=211;VDB=7.747402e-04;RPB=-1.940059e+00;AF1=0;AC1=0;DP4=122,39,6,2;MQ=60;FQ=-282;PV4=1,0.24,1,0.042;ACGTNacgtnPLUS=4,56,0,0,0,3,37,0,0,0;ACGTNacgtnMINUS=2,65,0,0,0,1,38,0,0,0	GT:PL:GQ	0/0:0,255,255:99	AGCCAGCCCC,GGGCAAGGAC	DP=250;DP5=167,79,0,0,0;DP5all=168,82,0,0,0;ACGTNacgtnHQ=0,167,0,0,0,0,79,0,0,0;ACGTNacgtn=0,168,0,0,0,0,82,0,0,0;VAF=0.00;TSR=0;PBINOM=8.84343660041662e-75	somatic	.	.	exonic	SLC15A3	nonsynonymous SNV	SLC15A3:ENST00000227880.3:exon7:c.G1561T:p.G521W,SLC15A3:ENST00000536784.1:exon1:c.G85T:p.G29W,	.	11q12.2	.	.	.	.	74;normScore=42.2	1	.	10	somatic	.	0	0	0	0	.	.	.	4	.	.	.	.	.	.	POLR2A	9
14	HLA-B*15:07	SILISGVTEF	SLISGVTEF	0	1	1	0	0	SILISGVTEF	14l12_NM_013381	0.5559270	122.1	0.3122	SB	14	HLA-B*15:07	SKLISGVTEF	SLISGVTEF	0	1	1	0	0	SKLISGVTEF	14l12_NM_013381	0.5511000	128.6	0.3336	SB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	2
15	HLA-B*15:07	ILISGVTEFL	ILISGVTEF	0	0	0	0	0	ILISGVTEF	14l12_NM_013381	0.3961280	688.0	1.5429	WB	15	HLA-B*15:07	KLISGVTEFL	KLISGVTEF	0	0	0	0	0	KLISGVTEF	14l12_NM_013381	0.4213100	523.9	1.2537	WB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	1
11	HLA-B*15:07	FMNSILISG	FMNSILISG	0	0	0	0	0	FMNSILISG	14l12_NM_013381	0.3784220	833.3	1.7756	WB	11	HLA-B*15:07	FMNSKLISG	FMNSKLISG	0	0	0	0	0	FMNSKLISG	14l12_NM_013381	0.3499310	1134.1	2.2497	nonB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	5
15	HLA-B*15:07	ILISGVTEF	ILISGVTEF	0	0	0	0	0	ILISGVTEF	14l12_NM_013381	0.6620630	38.7	0.0638	SB	15	HLA-B*15:07	KLISGVTEF	KLISGVTEF	0	0	0	0	0	KLISGVTEF	14l12_NM_013381	0.6844710	30.4	0.0384	SB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	1
14	HLA-B*15:07	RVKNQVTQL	RVKNQVTQL	0	0	0	0	0	RVKNQVTQL	16l14_NM_005956	0.4054710	621.8	1.4301	WB	14	HLA-B*15:07	RLKNQVTQL	RLKNQVTQL	0	0	0	0	0	RLKNQVTQL	16l14_NM_005956	0.4708800	306.4	0.7800	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	2
14	HLA-B*15:07	CVKAKSQPHF	CVKAKSQPF	0	8	1	0	0	CVKAKSQPHF	17l15_NM_001242	0.4694940	311.1	0.7905	WB	14	HLA-B*15:07	CAKAKSQPHF	CAKAKSQPF	0	8	1	0	0	CAKAKSQPHF	17l15_NM_001242	0.4050740	624.5	1.4347	WB	NM_001242786	c.C1058T	p.A353V	protein-altering	DLEIDRRDLSMPRCVKAKSQPHFPVLAQY	DLEIDRRDLSMPRCAKAKSQPHFPVLAQY	14	105685610	.	G	A	225	PASS	DP=197;VDB=5.232184e-05;RPB=5.656900e-01;AF1=0.5;AC1=1;DP4=48,54,27,19;MQ=60;FQ=225;PV4=0.34,0.15,1,1;ACGTNacgtnPLUS=11,0,24,0,0,14,0,36,0,0;ACGTNacgtnMINUS=18,0,24,0,0,22,0,46,0,0	GT:PL:GQ	0/1:255,0,255:99	TTTAGCCTTC,CACACCGGGG	DP=158;DP5=66,90,0,0,0;DP5all=68,90,0,0,0;ACGTNacgtnHQ=0,0,66,0,0,0,0,90,0,0;ACGTNacgtn=0,0,68,0,0,0,0,90,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	BRF1	nonsynonymous SNV	BRF1:ENST00000440513.3:exon13:c.C1058T:p.A353V,	.	14q32.33	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_18818	.	.	.	.	.	.	CGI(29%);score=71	.	NR3C1	2
10	HLA-B*15:07	SLCPMCGSRF	SLCPMCGSF	0	8	1	0	0	SLCPMCGSRF	18l16_NM_031885	0.4508550	380.6	0.9563	WB	10	HLA-B*15:07	SLCPMYGSRF	SLCPMYGSF	0	8	1	0	0	SLCPMYGSRF	18l16_NM_031885	0.4749620	293.2	0.7491	WB	NM_031885	c.A638G	p.Y213C	protein-altering	EMTETEIVTSLCPMCGSRFGYALSNGTVG	EMTETEIVTSLCPMYGSRFGYALSNGTVG	16	56540111	.	T	C	225	PASS	DP=290;VDB=1.037988e-01;RPB=2.896480e-01;AF1=0.5;AC1=1;DP4=66,51,69,40;MQ=60;FQ=225;PV4=0.72,1,1,1;ACGTNacgtnPLUS=0,36,0,34,0,0,43,0,33,0;ACGTNacgtnMINUS=0,33,0,31,0,0,31,0,44,0	GT:PL:GQ	0/1:255,0,255:99	TCGACTGCCA,ACATGGGACA	DP=126;DP5=50,76,0,0,0;DP5all=50,76,0,0,0;ACGTNacgtnHQ=0,0,0,50,0,0,0,0,76,0;ACGTNacgtn=0,0,0,50,0,0,0,0,76,0;VAF=0.00;TSR=0;PBINOM=1.1754943508223e-38	somatic	.	.	exonic	BBS2	nonsynonymous SNV	BBS2:ENST00000562012.1:exon2:c.A59G:p.Y20C,BBS2:ENST00000568104.1:exon6:c.A638G:p.Y213C,BBS2:ENST00000245157.5:exon6:c.A638G:p.Y213C,	.	16q12.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1783944;score=649	.	6
10	HLA-B*15:07	LLHPIPSIEY	LLHPIPSIY	0	8	1	0	0	LLHPIPSIEY	24l18_NM_199242	0.6143590	64.9	0.1389	SB	10	HLA-B*15:07	LLHPITSIEY	LLHPITSIY	0	8	1	0	0	LLHPITSIEY	24l18_NM_199242	0.6677130	36.4	0.0583	SB	NM_199242	c.A1126C	p.T376P	protein-altering	QSLEFPSSCLLHPIPSIEYQWIQGRLKAE	QSLEFPSSCLLHPITSIEYQWIQGRLKAE	17	73832929	.	T	G	-0	PASS	DP=168;VDB=1.486825e-03;RPB=-3.694597e+00;AF1=0;AC1=0;DP4=68,55,3,4;MQ=59;FQ=-223;PV4=0.51,1,1.1e-30,1.5e-07;ACGTNacgtnPLUS=0,0,3,35,0,0,0,7,42,0;ACGTNacgtnMINUS=0,0,0,31,0,0,0,0,40,0	GT:PL:GQ	0/0:0,196,255:99	TCGATGCTGG,GATGGGGTGC	DP=143;DP5=53,87,0,0,0;DP5all=55,88,0,0,0;ACGTNacgtnHQ=0,0,0,53,0,0,0,0,87,0;ACGTNacgtn=0,0,0,55,0,0,0,0,88,0;VAF=0.00;TSR=0;PBINOM=7.17464813734314e-43	somatic	.	.	exonic	UNC13D	nonsynonymous SNV	UNC13D:ENST00000412096.2:exon13:c.A1126C:p.T376P,UNC13D:ENST00000207549.4:exon13:c.A1126C:p.T376P,	.	17q25.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	9	.	.	.	.	.	PCS_2038706;score=618	.	6
11	HLA-B*15:07	FVQHAASGLW	FQHAASGLW	0	1	1	0	0	FVQHAASGLW	28l22_NM_000540	0.3942890	701.8	1.5666	WB	11	HLA-B*15:07	FVQHVASGLW	FQHVASGLW	0	1	1	0	0	FVQHVASGLW	28l22_NM_000540	0.3492550	1142.4	2.2615	nonB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	5
12	HLA-B*15:07	VQHAASGLWL	VQHAASGLL	0	8	1	0	0	VQHAASGLWL	28l22_NM_000540	0.3833170	790.3	1.7107	WB	12	HLA-B*15:07	VQHVASGLWL	VQHVASGLL	0	8	1	0	0	VQHVASGLWL	28l22_NM_000540	0.3576480	1043.3	2.1151	nonB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	4
14	HLA-B*15:07	HAASGLWLTY	HAASGLLTY	0	6	1	0	0	HAASGLWLTY	28l22_NM_000540	0.5564670	121.4	0.3098	SB	14	HLA-B*15:07	HVASGLWLTY	HVASGLLTY	0	6	1	0	0	HVASGLWLTY	28l22_NM_000540	0.5588990	118.2	0.2992	SB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	2
12	HLA-B*15:07	VQHAASGLW	VQHAASGLW	0	0	0	0	0	VQHAASGLW	28l22_NM_000540	0.4259410	498.3	1.2032	WB	12	HLA-B*15:07	VQHVASGLW	VQHVASGLW	0	0	0	0	0	VQHVASGLW	28l22_NM_000540	0.3834190	789.4	1.7094	WB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	4
15	HLA-B*15:07	AASGLWLTY	AASGLWLTY	0	0	0	0	0	AASGLWLTY	28l22_NM_000540	0.5061220	209.3	0.5561	WB	15	HLA-B*15:07	VASGLWLTY	VASGLWLTY	0	0	0	0	0	VASGLWLTY	28l22_NM_000540	0.4874500	256.1	0.6622	WB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	1
12	HLA-B*15:07	RIHASPSQSY	RIHASSQSY	0	5	1	0	0	RIHASPSQSY	38l26_NM_181622	0.6649610	37.5	0.0613	SB	12	HLA-B*15:07	RIHTSPSQSY	RIHSPSQSY	0	3	1	0	0	RIHTSPSQSY	38l26_NM_181622	0.6371890	50.7	0.1000	SB	NM_181622	c.A406G	p.T136A	protein-altering	CGSNGFRYLNYRIHASPSQSYRSRFCHPI	CGSNGFRYLNYRIHTSPSQSYRSRFCHPI	21	31797825	.	T	C	-0	PASS	DP=418;VDB=2.085269e-02;RPB=-1.564543e+00;AF1=0;AC1=0;DP4=198,123,14,3;MQ=60;FQ=-282;PV4=0.53,1,3.6e-13,1;ACGTNacgtnPLUS=0,11,0,77,0,0,5,0,77,0;ACGTNacgtnMINUS=0,3,0,121,0,0,5,0,112,0	GT:PL:GQ	0/0:0,255,255:99	GAAGGGGAGG,ATGGATTCTA	DP=209;DP5=97,104,0,0,0;DP5all=102,107,0,0,0;ACGTNacgtnHQ=0,0,0,97,0,0,0,0,104,0;ACGTNacgtn=0,0,0,102,0,0,0,0,107,0;VAF=0.00;TSR=0;PBINOM=3.11150763893051e-61	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.A406G:p.T136A,	.	21q22.11	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	4
15	HLA-B*15:07	KIHTSPSQSY	KIHSPSQSY	0	3	1	0	0	KIHTSPSQSY	39l27_NM_181622	0.5858800	88.3	0.2101	SB	15	HLA-B*15:07	RIHTSPSQSY	RIHSPSQSY	0	3	1	0	0	RIHTSPSQSY	39l27_NM_181622	0.6371890	50.7	0.1000	SB	NM_181622	c.G398A	p.R133K	protein-altering	SLGCGSNGFRYLNYKIHTSPSQSYRSRFC	SLGCGSNGFRYLNYRIHTSPSQSYRSRFC	21	31797833	.	C	T	-0	PASS	DP=426;VDB=1.985170e-02;RPB=-3.897429e-01;AF1=0;AC1=0;DP4=210,115,13,3;MQ=60;FQ=-282;PV4=1,1,2e-13,1;ACGTNacgtnPLUS=0,83,0,10,0,0,75,0,6,0;ACGTNacgtnMINUS=0,126,0,3,0,0,110,0,5,0	GT:PL:GQ	0/0:0,255,255:99	GGTATGGATT,TATAATTCAG	DP=217;DP5=97,107,0,1,0;DP5all=100,114,0,1,2;ACGTNacgtnHQ=0,97,0,0,0,0,107,0,1,0;ACGTNacgtn=0,100,0,0,0,2,114,0,1,0;VAF=0.00;TSR=1;PBINOM=4.00606608512319e-60	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.G398A:p.R133K,	.	21q22.11	.	.	.	.	.	1	.	10	LQVSIG	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	1
6	HLA-B*15:07	KMVLTRAKAL	KMVLTRAAL	0	7	1	0	0	KMVLTRAKAL	40l28_NM_001271	0.4423750	417.1	1.0393	WB	6	HLA-B*15:07	KMVLTRAKAS	KMVLTRAAS	0	7	1	0	0	KMVLTRAKAS	40l28_NM_001271	0.2008860	5688.7	8.0053	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	10
6	HLA-C*03:03	RMASHTGRL	RMASHTGRL	0	0	0	0	0	RMASHTGRL	4l4_NM_00100469	0.3833300	790.2	1.3182	WB	6	HLA-C*03:03	RMANHTGRL	RMANHTGRL	0	0	0	0	0	RMANHTGRL	4l4_NM_00100469	0.3650360	963.1	1.4803	WB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	4
12	HLA-C*03:03	FVQPSLGFVAL	FVQPSFVAL	0	5	2	0	0	FVQPSLGFVAL	5l5_NM_00100841	0.3379720	1290.8	1.7517	WB	12	HLA-C*03:03	FVQSSLGFVAL	FVQSSFVAL	0	5	2	0	0	FVQSSLGFVAL	5l5_NM_00100841	0.2898770	2171.9	2.3919	nonB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	4
10	HLA-C*03:03	FSFVQPSLGF	FSFQPSLGF	0	3	1	0	0	FSFVQPSLGF	5l5_NM_00100841	0.4526570	373.2	0.8222	WB	10	HLA-C*03:03	FSFVQSSLGF	FSFQSSLGF	0	3	1	0	0	FSFVQSSLGF	5l5_NM_00100841	0.4574680	354.3	0.7951	WB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	6
12	HLA-C*03:03	FVQPSLGFV	FVQPSLGFV	0	0	0	0	0	FVQPSLGFV	5l5_NM_00100841	0.4396390	429.7	0.8987	WB	12	HLA-C*03:03	FVQSSLGFV	FVQSSLGFV	0	0	0	0	0	FVQSSLGFV	5l5_NM_00100841	0.3670770	942.1	1.4617	WB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	4
14	HLA-C*03:03	QPSLGFVAL	QPSLGFVAL	0	0	0	0	0	QPSLGFVAL	5l5_NM_00100841	0.3205290	1558.9	1.9451	WB	14	HLA-C*03:03	QSSLGFVAL	QSSLGFVAL	0	0	0	0	0	QSSLGFVAL	5l5_NM_00100841	0.5467070	134.9	0.4390	SB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	2
10	HLA-C*03:03	FSFVQPSL	FSF-VQPSL	0	0	0	3	1	FSFVQPSL	5l5_NM_00100841	0.5057890	210.0	0.5811	WB	10	HLA-C*03:03	FSFVQSSL	FSF-VQSSL	0	0	0	3	1	FSFVQSSL	5l5_NM_00100841	0.5335310	155.6	0.4790	SB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	6
14	HLA-C*03:03	VPASVFSVL	VPASVFSVL	0	0	0	0	0	VPASVFSVL	12l10_NM_138421	0.5631710	112.9	0.3910	SB	14	HLA-C*03:03	VLASVFSVL	VLASVFSVL	0	0	0	0	0	VLASVFSVL	12l10_NM_138421	0.5436010	139.5	0.4484	SB	NM_138421	c.T968C	p.L323P	protein-altering	SDDPPIILQEQKTVPASVFSVLSAIYASQ	SDDPPIILQEQKTVLASVFSVLSAIYASQ	11	18108487	.	A	G	225	PASS	DP=416;VDB=2.454252e-01;RPB=7.889910e-01;AF1=0.5;AC1=1;DP4=140,69,73,33;MQ=60;FQ=225;PV4=1,0.22,1,1;ACGTNacgtnPLUS=67,0,43,0,0,69,0,43,0,0;ACGTNacgtnMINUS=72,0,31,0,0,59,0,25,0,0	GT:PL:GQ	0/1:255,0,255:99	AACAGAGGCT,GCACTGTTTT	DP=180;DP5=92,84,0,0,0;DP5all=94,86,0,0,0;ACGTNacgtnHQ=92,0,0,0,0,84,0,0,0,0;ACGTNacgtn=94,0,0,0,0,86,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.04404871487976e-53	somatic	.	.	exonic	SAAL1	nonsynonymous SNV	SAAL1:ENST00000531751.1:exon6:c.T635C:p.L212P,SAAL1:ENST00000531581.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000529318.1:exon9:c.T968C:p.L323P,SAAL1:ENST00000300013.4:exon9:c.T968C:p.L323P,SAAL1:ENST00000524803.1:exon9:c.T968C:p.L323P,	.	11p15.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_742229;score=516	.	2
8	HLA-C*03:03	EALFMNSIL	EALFMNSIL	0	0	0	0	0	EALFMNSIL	14l12_NM_013381	0.3981040	673.4	1.1984	WB	8	HLA-C*03:03	EALFMNSKL	EALFMNSKL	0	0	0	0	0	EALFMNSKL	14l12_NM_013381	0.2986180	1975.9	2.2617	nonB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	8
15	HLA-C*03:03	ILISGVTEF	ILISGVTEF	0	0	0	0	0	ILISGVTEF	14l12_NM_013381	0.5718760	102.7	0.3694	SB	15	HLA-C*03:03	KLISGVTEF	KLISGVTEF	0	0	0	0	0	KLISGVTEF	14l12_NM_013381	0.4487020	389.5	0.8454	WB	NM_013381	c.A2879T	p.K960I	protein-altering	ILNTRYGEALFMNSILISGVTEFLNTEGE	ILNTRYGEALFMNSKLISGVTEFLNTEGE	12	73050736	.	A	T	222	PASS	DP=246;VDB=9.453623e-03;RPB=-7.530487e-01;AF1=0.5;AC1=1;DP4=94,26,45,7;MQ=60;FQ=223;PV4=0.78,0.22,1,0.46;ACGTNacgtnPLUS=50,0,0,28,0,39,0,0,18,0;ACGTNacgtnMINUS=44,0,0,20,0,31,0,0,13,0	GT:PL:GQ	0/1:252,0,255:99	ATGAATTCCA,ACTCATCAGT	DP=83;DP5=49,34,0,0,0;DP5all=49,34,0,0,0;ACGTNacgtnHQ=49,0,0,0,0,34,0,0,0,0;ACGTNacgtn=49,0,0,0,0,34,0,0,0,0;VAF=0.00;TSR=0;PBINOM=1.03397576569128e-25	somatic	.	.	exonic	TRHDE	nonsynonymous SNV	TRHDE:ENST00000261180.4:exon18:c.A2879T:p.K960I,	.	12q21.1	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1097440;score=644	.	1
7	HLA-C*03:03	ISAQIRARV	ISAQIRARV	0	0	0	0	0	ISAQIRARV	16l14_NM_005956	0.3172310	1615.5	1.9868	WB	7	HLA-C*03:03	ISAQIRARL	ISAQIRARL	0	0	0	0	0	ISAQIRARL	16l14_NM_005956	0.4979670	228.6	0.6128	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	9
11	HLA-C*03:03	FVQHAASGL	FVQHAASGL	0	0	0	0	0	FVQHAASGL	28l22_NM_000540	0.5897310	84.7	0.3250	SB	11	HLA-C*03:03	FVQHVASGL	FVQHVASGL	0	0	0	0	0	FVQHVASGL	28l22_NM_000540	0.5414100	142.9	0.4550	SB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	5
2	HLA-C*03:03	YRLQWLLPV	YRLQWLLPV	0	0	0	0	0	YRLQWLLPV	31l25_NM_001167	0.3223150	1529.0	1.9226	WB	2	HLA-C*03:03	YCLQWLLPV	YCLQWLLPV	0	0	0	0	0	YCLQWLLPV	31l25_NM_001167	0.3163210	1631.5	1.9982	WB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	2
7	HLA-C*03:03	MVLTRAKAL	MVLTRAKAL	0	0	0	0	0	MVLTRAKAL	40l28_NM_001271	0.5230400	174.3	0.5139	WB	7	HLA-C*03:03	MVLTRAKAS	MVLTRAKAS	0	0	0	0	0	MVLTRAKAS	40l28_NM_001271	0.0811050	20790.3	14.9749	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	9
9	HLA-C*03:03	LTRAKALEL	LTRAKALEL	0	0	0	0	0	LTRAKALEL	40l28_NM_001271	0.4080840	604.5	1.1165	WB	9	HLA-C*03:03	LTRAKASEL	LTRAKASEL	0	0	0	0	0	LTRAKASEL	40l28_NM_001271	0.4025880	641.5	1.1616	WB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	7
10	HLA-C*07:01	FYTNVQPHSY	FYTNVPHSY	0	5	1	0	0	FYTNVQPHSY	3l3_NM_00100413	0.2665680	2795.0	0.9566	WB	10	HLA-C*07:01	FYTNVLPHSY	FYTNVPHSY	0	5	1	0	0	FYTNVLPHSY	3l3_NM_00100413	0.2847040	2297.0	0.7779	WB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	6
11	HLA-C*07:01	YTNVQPHSY	YTNVQPHSY	0	0	0	0	0	YTNVQPHSY	3l3_NM_00100413	0.3273120	1448.6	0.4790	SB	11	HLA-C*07:01	YTNVLPHSY	YTNVLPHSY	0	0	0	0	0	YTNVLPHSY	3l3_NM_00100413	0.3692110	920.6	0.3109	SB	NM_001004136	c.T785A	p.L262Q	protein-altering	VVSVFYGAAFYTNVQPHSYHTPEKDKVVS	VVSVFYGAAFYTNVLPHSYHTPEKDKVVS	1	248616883	rs143551105	T	A	23	PASS	DP=56;VDB=1.225870e-01;RPB=1.420429e+00;AF1=0.5;AC1=1;DP4=47,0,7,1;MQ=40;FQ=26;PV4=0.15,0.0078,1,1;ACGTNacgtnPLUS=4,0,0,27,0,1,0,0,0,0;ACGTNacgtnMINUS=3,0,0,20,0,0,0,0,0,0	GT:PL:GQ	0/1:53,0,124:56	ACCAACGTGC,GCCCCACTCC	DP=97;DP5=29,65,3,0,0;DP5all=29,65,3,0,0;ACGTNacgtnHQ=3,0,0,29,0,0,0,0,65,0;ACGTNacgtn=3,0,0,29,0,0,0,0,65,0;VAF=0.03;TSR=3;PBINOM=9.60479172873646e-25	somatic	MATCH=exact;RS=143551105;RSPOS=248616883;dbSNPBuildID=137;SSR=0;SAO=0;VP=0x050000000a05040002000100;WGT=1;VC=SNV;NSM;REF;ASP;VLD;OTHERKG;ID=rs143551105	.	exonic	OR2T2	nonsynonymous SNV	OR2T2:ENST00000342927.3:exon1:c.T785A:p.L262Q,	Score=0.979009;Name=chr1:248795555	1q44	.	.	.	.	335;normScore=86.7	0.5	.	8	SNP_support_germline	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
5	HLA-C*07:01	TRMASHTGRL	TRMASHTGL	0	8	1	0	0	TRMASHTGRL	4l4_NM_00100469	0.3365360	1311.0	0.4352	SB	5	HLA-C*07:01	TRMANHTGRL	TRMAHTGRL	0	4	1	0	0	TRMANHTGRL	4l4_NM_00100469	0.3412170	1246.2	0.4130	SB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
6	HLA-C*07:01	RMASHTGRL	RMASHTGRL	0	0	0	0	0	RMASHTGRL	4l4_NM_00100469	0.2298880	4156.6	1.4752	WB	6	HLA-C*07:01	RMANHTGRL	RMANHTGRL	0	0	0	0	0	RMANHTGRL	4l4_NM_00100469	0.2475370	3434.0	1.1914	WB	NM_001004694	c.A26G	p.N9S	protein-altering	MANITRMASHTGRLDFILMGLFR	MANITRMANHTGRLDFILMGLFR	1	248722767	.	T	C	66	PASS	DP=58;VDB=2.534406e-03;RPB=5.081490e+00;AF1=0.5;AC1=1;DP4=27,0,1,9;MQ=47;FQ=69;PV4=0.0023,0.0052,0.037,2.8e-14;ACGTNacgtnPLUS=0,1,0,16,0,0,5,0,10,0;ACGTNacgtnMINUS=0,0,0,11,0,0,6,0,7,0	GT:PL:GQ	0/1:96,0,255:99	TCCAGTGTGG,TGGCCATCCT	DP=185;DP5=67,111,1,4,0;DP5all=69,111,1,4,0;ACGTNacgtnHQ=0,1,0,67,0,0,4,0,111,0;ACGTNacgtn=0,1,0,69,0,0,4,0,111,0;VAF=0.03;TSR=5;PBINOM=1.35796162175073e-46	somatic	.	.	exonic	OR2T29	nonsynonymous SNV	OR2T29:ENST00000328570.3:exon1:c.A26G:p.N9S,	Score=0.986121;Name=chr1:248623087	1q44	.	.	.	.	335;normScore=86.7&127517;normScore=76.1	0.5	.	8	LQVSIG	Segmental_dup(-2)	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	4
7	HLA-C*07:01	WREFSFVQPSL	WRSFVQPSL	0	2	2	0	0	WREFSFVQPSL	5l5_NM_00100841	0.2168830	4784.6	1.7101	WB	7	HLA-C*07:01	WREFSFVQSSL	WRSFVQSSL	0	2	2	0	0	WREFSFVQSSL	5l5_NM_00100841	0.2338170	3983.6	1.3982	WB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	9
10	HLA-C*07:01	FSFVQPSLGF	FSFVQPSLF	0	8	1	0	0	FSFVQPSLGF	5l5_NM_00100841	0.2402090	3717.4	1.3067	WB	10	HLA-C*07:01	FSFVQSSLGF	FSFQSSLGF	0	3	1	0	0	FSFVQSSLGF	5l5_NM_00100841	0.2039940	5500.6	2.0074	nonB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	6
11	HLA-C*07:01	SFVQPSLGF	SFVQPSLGF	0	0	0	0	0	SFVQPSLGF	5l5_NM_00100841	0.2097330	5169.4	1.8679	WB	11	HLA-C*07:01	SFVQSSLGF	SFVQSSLGF	0	0	0	0	0	SFVQSSLGF	5l5_NM_00100841	0.1913170	6309.2	2.3646	nonB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	5
12	HLA-C*07:01	FVQPSLGFV	FVQPSLGFV	0	0	0	0	0	FVQPSLGFV	5l5_NM_00100841	0.2667160	2790.5	0.9548	WB	12	HLA-C*07:01	FVQSSLGFV	FVQSSLGFV	0	0	0	0	0	FVQSSLGFV	5l5_NM_00100841	0.2133480	4971.1	1.7842	WB	NM_001008410	c.T1186C	p.S396P	protein-altering	IANSLNWREFSFVQPSLGFVALVLSTLHT	IANSLNWREFSFVQSSLGFVALVLSTLHT	2	120020633	.	T	C	184	PASS	DP=172;VDB=8.498968e-02;RPB=6.863685e-01;AF1=0.5;AC1=1;DP4=87,13,34,5;MQ=60;FQ=187;PV4=1,0.27,1,1;ACGTNacgtnPLUS=0,20,0,51,0,0,8,0,17,0;ACGTNacgtnMINUS=0,15,0,36,0,0,5,0,19,0	GT:PL:GQ	0/1:214,0,255:99	CCCTCCACAG,CCTCACTGGG	DP=91;DP5=68,20,0,0,0;DP5all=71,20,0,0,0;ACGTNacgtnHQ=0,0,0,68,0,0,0,0,20,0;ACGTNacgtn=0,0,0,71,0,0,0,0,20,0;VAF=0.00;TSR=0;PBINOM=3.23117426778526e-27	somatic	.	.	exonic	STEAP3	nonsynonymous SNV	STEAP3:ENST00000393106.2:exon6:c.T1186C:p.S396P,STEAP3:ENST00000425223.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000354888.5:exon6:c.T1186C:p.S396P,STEAP3:ENST00000393107.2:exon5:c.T1186C:p.S396P,STEAP3:ENST00000393110.2:exon6:c.T1216C:p.S406P,STEAP3:ENST00000393108.2:exon5:c.T1186C:p.S396P,	.	2q14.2	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	6	.	.	.	.	CGI(47%);score=53	.	.	4
13	HLA-C*07:01	ARVKNQVTQL	ARVNQVTQL	0	3	1	0	0	ARVKNQVTQL	16l14_NM_005956	0.2396180	3741.2	1.3152	WB	13	HLA-C*07:01	ARLKNQVTQL	ARLNQVTQL	0	3	1	0	0	ARLKNQVTQL	16l14_NM_005956	0.2435650	3584.8	1.2531	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	3
11	HLA-C*07:01	IRARVKNQV	IRARVKNQV	0	0	0	0	0	IRARVKNQV	16l14_NM_005956	0.3529930	1097.2	0.3681	SB	11	HLA-C*07:01	IRARLKNQV	IRARLKNQV	0	0	0	0	0	IRARLKNQV	16l14_NM_005956	0.3282920	1433.3	0.4744	SB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	5
14	HLA-C*07:01	RVKNQVTQL	RVKNQVTQL	0	0	0	0	0	RVKNQVTQL	16l14_NM_005956	0.2633800	2893.0	0.9948	WB	14	HLA-C*07:01	RLKNQVTQL	RLKNQVTQL	0	0	0	0	0	RLKNQVTQL	16l14_NM_005956	0.2378350	3814.1	1.3407	WB	NM_005956	c.C58G	p.L20V	protein-altering	ILNGKEISAQIRARVKNQVTQLKEQVPGF	ILNGKEISAQIRARLKNQVTQLKEQVPGF	14	64867527	.	C	G	225	PASS	DP=162;VDB=1.017451e-01;RPB=5.657209e-01;AF1=0.5;AC1=1;DP4=58,30,27,10;MQ=60;FQ=225;PV4=1,0.37,1,0.26;ACGTNacgtnPLUS=0,25,15,0,0,0,27,14,0,0;ACGTNacgtnMINUS=0,33,12,0,0,0,24,12,0,0	GT:PL:GQ	0/1:255,0,255:99	AAGGGCGAGA,TGAAAAATCA	DP=117;DP5=65,52,0,0,0;DP5all=65,52,0,0,0;ACGTNacgtnHQ=0,65,0,0,0,0,52,0,0,0;ACGTNacgtn=0,65,0,0,0,0,52,0,0,0;VAF=0.00;TSR=0;PBINOM=6.01853107621018e-36	somatic	.	.	exonic	MTHFD1	nonsynonymous SNV	MTHFD1:ENST00000545908.1:exon2:c.C226G:p.L76V,MTHFD1:ENST00000216605.8:exon2:c.C58G:p.L20V,MTHFD1:ENST00000555709.2:exon2:c.C226G:p.L76V,	.	14q23.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	PCS_1445155;score=409	.	2
12	HLA-C*07:01	YRPFYEEMLRF	YRYEEMLRF	0	2	2	0	0	YRPFYEEMLRF	19l17_NM_001135	0.2984570	1979.4	0.6629	WB	12	HLA-C*07:01	YRPSYEEMLRF	YRYEEMLRF	0	2	2	0	0	YRPSYEEMLRF	19l17_NM_001135	0.3156950	1642.6	0.5452	WB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	4
11	HLA-C*07:01	SYRPFYEEML	SYRPFYEML	0	6	1	0	0	SYRPFYEEML	19l17_NM_001135	0.2100720	5150.5	1.8599	WB	11	HLA-C*07:01	SYRPSYEEML	SYRPSYEML	0	6	1	0	0	SYRPSYEEML	19l17_NM_001135	0.2036030	5523.9	2.0185	nonB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	5
11	HLA-C*07:01	SYRPFYEEM	SYRPFYEEM	0	0	0	0	0	SYRPFYEEM	19l17_NM_001135	0.4215340	522.6	0.1774	SB	11	HLA-C*07:01	SYRPSYEEM	SYRPSYEEM	0	0	0	0	0	SYRPSYEEM	19l17_NM_001135	0.3634880	979.4	0.3311	SB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	5
12	HLA-C*07:01	YRPFYEEML	YRPFYEEML	0	0	0	0	0	YRPFYEEML	19l17_NM_001135	0.4184940	540.1	0.1831	SB	12	HLA-C*07:01	YRPSYEEML	YRPSYEEML	0	0	0	0	0	YRPSYEEML	19l17_NM_001135	0.4391840	431.8	0.1482	SB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	4
15	HLA-C*07:01	FYEEMLRFY	FYEEMLRFY	0	0	0	0	0	FYEEMLRFY	19l17_NM_001135	0.2932480	2094.1	0.7015	WB	15	HLA-C*07:01	SYEEMLRFY	SYEEMLRFY	0	0	0	0	0	SYEEMLRFY	19l17_NM_001135	0.2517750	3280.1	1.1396	WB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	1
12	HLA-C*07:01	YRPFYEEM	YR-PFYEEM	0	0	0	2	1	YRPFYEEM	19l17_NM_001135	0.3272840	1449.0	0.4791	SB	12	HLA-C*07:01	YRPSYEEM	YR-PSYEEM	0	0	0	2	1	YRPSYEEM	19l17_NM_001135	0.2868700	2243.8	0.7585	WB	NM_001135704	c.C104T	p.S35F	protein-altering	SVIQNLPKNGSYRPFYEEMLRFYSYYKQA	SVIQNLPKNGSYRPSYEEMLRFYSYYKQA	17	43213882	.	C	T	225	PASS	DP=172;VDB=2.274701e-01;RPB=9.079975e-01;AF1=0.5;AC1=1;DP4=31,6,80,12;MQ=60;FQ=204;PV4=0.86,0.058,1,1;ACGTNacgtnPLUS=0,14,0,49,0,0,6,0,21,0;ACGTNacgtnMINUS=0,17,0,35,0,0,10,0,18,0	GT:PL:GQ	0/1:255,0,231:99	TACCGCCCCT,CTATGAAGAG	DP=103;DP5=60,43,0,0,0;DP5all=60,43,0,0,0;ACGTNacgtnHQ=0,60,0,0,0,0,43,0,0,0;ACGTNacgtn=0,60,0,0,0,0,43,0,0,0;VAF=0.00;TSR=0;PBINOM=9.86076131526275e-32	somatic	.	.	exonic	ACBD4	nonsynonymous SNV	ACBD4:ENST00000591859.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000376955.4:exon3:c.C104T:p.S35F,ACBD4:ENST00000586346.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000398322.3:exon2:c.C104T:p.S35F,ACBD4:ENST00000592162.1:exon3:c.C104T:p.S35F,ACBD4:ENST00000431281.1:exon5:c.C104T:p.S35F,ACBD4:ENST00000321854.8:exon3:c.C104T:p.S35F,	.	17q21.31	.	.	.	.	194;normScore=26.3&225;normScore=48.6	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	CGI(27%);score=73	PCS_1964896;score=555	.	4
13	HLA-C*07:01	QHAASGLWL	QHAASGLWL	0	0	0	0	0	QHAASGLWL	28l22_NM_000540	0.2372190	3839.6	1.3495	WB	13	HLA-C*07:01	QHVASGLWL	QHVASGLWL	0	0	0	0	0	QHVASGLWL	28l22_NM_000540	0.2285660	4216.4	1.5013	WB	NM_000540	c.T1049C	p.V350A	protein-altering	PEIKYGESLCFVQHAASGLWLTYAAPDPK	PEIKYGESLCFVQHVASGLWLTYAAPDPK	19	38939380	.	T	C	225	PASS	DP=162;VDB=9.802628e-03;RPB=-5.538405e-01;AF1=0.5;AC1=1;DP4=51,36,21,15;MQ=60;FQ=225;PV4=0.86,1,1,1;ACGTNacgtnPLUS=0,11,0,20,0,0,15,0,30,0;ACGTNacgtnMINUS=0,11,0,30,0,0,14,0,29,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCATG,GGCCTCAGGA	DP=215;DP5=82,131,0,0,0;DP5all=83,132,0,0,0;ACGTNacgtnHQ=0,0,0,82,0,0,0,0,131,0;ACGTNacgtn=0,0,0,83,0,0,0,0,132,0;VAF=0.00;TSR=0;PBINOM=7.59645419660777e-65	somatic	.	.	exonic	RYR1	nonsynonymous SNV	RYR1:ENST00000355481.4:exon11:c.T1049C:p.V350A,RYR1:ENST00000359596.3:exon11:c.T1049C:p.V350A,RYR1:ENST00000360985.3:exon11:c.T1049C:p.V350A,	.	19q13.2	.	.	.	.	123;normScore=32.9	1	.	10	somatic	.	0	0	0	0	.	.	.	2	.	.	.	.	.	PCS_2258712;score=500	.	3
2	HLA-C*07:01	YRLQWLLPVLL	YRLQWPVLL	0	5	2	0	0	YRLQWLLPVLL	31l25_NM_001167	0.3924360	716.0	0.2506	SB	2	HLA-C*07:01	YCLQWLLPVLL	YQWLLPVLL	0	1	2	0	0	YCLQWLLPVLL	31l25_NM_001167	0.0515520	28623.9	24.4159	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	2
1	HLA-C*07:01	MYRLQWLLPV	MRLQWLLPV	0	1	1	0	0	MYRLQWLLPV	31l25_NM_001167	0.2997910	1951.0	0.6530	WB	1	HLA-C*07:01	MYCLQWLLPV	MYLQWLLPV	0	2	1	0	0	MYCLQWLLPV	31l25_NM_001167	0.1304400	12190.9	5.6090	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	3
2	HLA-C*07:01	YRLQWLLPVL	YRLQWLPVL	0	5	1	0	0	YRLQWLLPVL	31l25_NM_001167	0.4987020	226.8	0.0844	SB	2	HLA-C*07:01	YCLQWLLPVL	YLQWLLPVL	0	1	1	0	0	YCLQWLLPVL	31l25_NM_001167	0.0724740	22825.3	15.3099	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	2
2	HLA-C*07:01	YRLQWLLPV	YRLQWLLPV	0	0	0	0	0	YRLQWLLPV	31l25_NM_001167	0.5782720	95.9	0.0363	SB	2	HLA-C*07:01	YCLQWLLPV	YCLQWLLPV	0	0	0	0	0	YCLQWLLPV	31l25_NM_001167	0.0903980	18801.5	10.8916	nonB	NM_001167821	c.T7C	p.C3R	protein-altering	MYRLQWLLPVLLIPKPL	MYCLQWLLPVLLIPKPL	20	36147570	.	A	G	-0	PASS	DP=337;VDB=3.551516e-02;RPB=1.818462e+00;AF1=0;AC1=0;DP4=85,173,2,13;MQ=60;FQ=-282;PV4=0.26,0.27,0.00025,1;ACGTNacgtnPLUS=47,0,2,0,0,121,0,12,0,0;ACGTNacgtnMINUS=36,0,0,0,0,107,0,3,0,0	GT:PL:GQ	0/0:0,255,255:99	CACTGGAGGC,ATACATGATC	DP=101;DP5=34,66,0,0,0;DP5all=34,67,0,0,0;ACGTNacgtnHQ=34,0,0,0,0,66,0,0,0,0;ACGTNacgtn=34,0,0,0,0,67,0,0,0,0;VAF=0.00;TSR=0;PBINOM=7.88860905221007e-31	somatic	.	.	exonic	BLCAP	nonsynonymous SNV	BLCAP:ENST00000432507.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397137.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000456058.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000445723.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414080.1:exon3:c.T7C:p.C3R,BLCAP:ENST00000414542.2:exon3:c.T7C:p.C3R,BLCAP:ENST00000373537.2:exon2:c.T7C:p.C3R,BLCAP:ENST00000397135.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397134.1:exon2:c.T7C:p.C3R,BLCAP:ENST00000397131.1:exon2:c.T7C:p.C3R,	.	20q11.23	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	35	.	.	.	.	CGI(20%);score=80	PCS_2814442;score=553	GATA2	2
11	HLA-C*07:01	YRIHASPSQSY	YRISPSQSY	0	3	2	0	0	YRIHASPSQSY	38l26_NM_181622	0.2908280	2149.7	0.7232	WB	11	HLA-C*07:01	YRIHTSPSQSY	YRISPSQSY	0	3	2	0	0	YRIHTSPSQSY	38l26_NM_181622	0.2789850	2443.6	0.8296	WB	NM_181622	c.A406G	p.T136A	protein-altering	CGSNGFRYLNYRIHASPSQSYRSRFCHPI	CGSNGFRYLNYRIHTSPSQSYRSRFCHPI	21	31797825	.	T	C	-0	PASS	DP=418;VDB=2.085269e-02;RPB=-1.564543e+00;AF1=0;AC1=0;DP4=198,123,14,3;MQ=60;FQ=-282;PV4=0.53,1,3.6e-13,1;ACGTNacgtnPLUS=0,11,0,77,0,0,5,0,77,0;ACGTNacgtnMINUS=0,3,0,121,0,0,5,0,112,0	GT:PL:GQ	0/0:0,255,255:99	GAAGGGGAGG,ATGGATTCTA	DP=209;DP5=97,104,0,0,0;DP5all=102,107,0,0,0;ACGTNacgtnHQ=0,0,0,97,0,0,0,0,104,0;ACGTNacgtn=0,0,0,102,0,0,0,0,107,0;VAF=0.00;TSR=0;PBINOM=3.11150763893051e-61	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.A406G:p.T136A,	.	21q22.11	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	5
6	HLA-C*07:01	FRYLNYRIHA	FRYNYRIHA	0	3	1	0	0	FRYLNYRIHA	38l26_NM_181622	0.2836830	2322.5	0.7870	WB	6	HLA-C*07:01	FRYLNYRIHT	FRYNYRIHT	0	3	1	0	0	FRYLNYRIHT	38l26_NM_181622	0.1866010	6639.5	2.4975	nonB	NM_181622	c.A406G	p.T136A	protein-altering	CGSNGFRYLNYRIHASPSQSYRSRFCHPI	CGSNGFRYLNYRIHTSPSQSYRSRFCHPI	21	31797825	.	T	C	-0	PASS	DP=418;VDB=2.085269e-02;RPB=-1.564543e+00;AF1=0;AC1=0;DP4=198,123,14,3;MQ=60;FQ=-282;PV4=0.53,1,3.6e-13,1;ACGTNacgtnPLUS=0,11,0,77,0,0,5,0,77,0;ACGTNacgtnMINUS=0,3,0,121,0,0,5,0,112,0	GT:PL:GQ	0/0:0,255,255:99	GAAGGGGAGG,ATGGATTCTA	DP=209;DP5=97,104,0,0,0;DP5all=102,107,0,0,0;ACGTNacgtnHQ=0,0,0,97,0,0,0,0,104,0;ACGTNacgtn=0,0,0,102,0,0,0,0,107,0;VAF=0.00;TSR=0;PBINOM=3.11150763893051e-61	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.A406G:p.T136A,	.	21q22.11	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	10
13	HLA-C*07:01	IHASPSQSY	IHASPSQSY	0	0	0	0	0	IHASPSQSY	38l26_NM_181622	0.2645630	2856.3	0.9806	WB	13	HLA-C*07:01	IHTSPSQSY	IHTSPSQSY	0	0	0	0	0	IHTSPSQSY	38l26_NM_181622	0.2258480	4342.3	1.5533	WB	NM_181622	c.A406G	p.T136A	protein-altering	CGSNGFRYLNYRIHASPSQSYRSRFCHPI	CGSNGFRYLNYRIHTSPSQSYRSRFCHPI	21	31797825	.	T	C	-0	PASS	DP=418;VDB=2.085269e-02;RPB=-1.564543e+00;AF1=0;AC1=0;DP4=198,123,14,3;MQ=60;FQ=-282;PV4=0.53,1,3.6e-13,1;ACGTNacgtnPLUS=0,11,0,77,0,0,5,0,77,0;ACGTNacgtnMINUS=0,3,0,121,0,0,5,0,112,0	GT:PL:GQ	0/0:0,255,255:99	GAAGGGGAGG,ATGGATTCTA	DP=209;DP5=97,104,0,0,0;DP5all=102,107,0,0,0;ACGTNacgtnHQ=0,0,0,97,0,0,0,0,104,0;ACGTNacgtn=0,0,0,102,0,0,0,0,107,0;VAF=0.00;TSR=0;PBINOM=3.11150763893051e-61	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.A406G:p.T136A,	.	21q22.11	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	3
9	HLA-C*07:01	FRYLNYKIH	FRYLNYKIH	0	0	0	0	0	FRYLNYKIH	39l27_NM_181622	0.2531560	3231.5	1.1228	WB	9	HLA-C*07:01	FRYLNYRIH	FRYLNYRIH	0	0	0	0	0	FRYLNYRIH	39l27_NM_181622	0.3095660	1755.2	0.5838	WB	NM_181622	c.G398A	p.R133K	protein-altering	SLGCGSNGFRYLNYKIHTSPSQSYRSRFC	SLGCGSNGFRYLNYRIHTSPSQSYRSRFC	21	31797833	.	C	T	-0	PASS	DP=426;VDB=1.985170e-02;RPB=-3.897429e-01;AF1=0;AC1=0;DP4=210,115,13,3;MQ=60;FQ=-282;PV4=1,1,2e-13,1;ACGTNacgtnPLUS=0,83,0,10,0,0,75,0,6,0;ACGTNacgtnMINUS=0,126,0,3,0,0,110,0,5,0	GT:PL:GQ	0/0:0,255,255:99	GGTATGGATT,TATAATTCAG	DP=217;DP5=97,107,0,1,0;DP5all=100,114,0,1,2;ACGTNacgtnHQ=0,97,0,0,0,0,107,0,1,0;ACGTNacgtn=0,100,0,0,0,2,114,0,1,0;VAF=0.00;TSR=1;PBINOM=4.00606608512319e-60	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.G398A:p.R133K,	.	21q22.11	.	.	.	.	.	1	.	10	LQVSIG	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	7
9	HLA-C*07:01	FRYLNYKI	FRYLN-YKI	0	0	0	5	1	FRYLNYKI	39l27_NM_181622	0.3251820	1482.3	0.4891	SB	9	HLA-C*07:01	FRYLNYRI	FRYLNYR-I	0	0	0	7	1	FRYLNYRI	39l27_NM_181622	0.3485200	1151.6	0.3839	SB	NM_181622	c.G398A	p.R133K	protein-altering	SLGCGSNGFRYLNYKIHTSPSQSYRSRFC	SLGCGSNGFRYLNYRIHTSPSQSYRSRFC	21	31797833	.	C	T	-0	PASS	DP=426;VDB=1.985170e-02;RPB=-3.897429e-01;AF1=0;AC1=0;DP4=210,115,13,3;MQ=60;FQ=-282;PV4=1,1,2e-13,1;ACGTNacgtnPLUS=0,83,0,10,0,0,75,0,6,0;ACGTNacgtnMINUS=0,126,0,3,0,0,110,0,5,0	GT:PL:GQ	0/0:0,255,255:99	GGTATGGATT,TATAATTCAG	DP=217;DP5=97,107,0,1,0;DP5all=100,114,0,1,2;ACGTNacgtnHQ=0,97,0,0,0,0,107,0,1,0;ACGTNacgtn=0,100,0,0,0,2,114,0,1,0;VAF=0.00;TSR=1;PBINOM=4.00606608512319e-60	somatic	.	.	exonic	KRTAP13-3	nonsynonymous SNV	KRTAP13-3:ENST00000390690.2:exon1:c.G398A:p.R133K,	.	21q22.11	.	.	.	.	.	1	.	10	LQVSIG	.	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	7
7	HLA-C*07:01	MVLTRAKAL	MVLTRAKAL	0	0	0	0	0	MVLTRAKAL	40l28_NM_001271	0.2579720	3067.4	1.0627	WB	7	HLA-C*07:01	MVLTRAKAS	MVLTRAKAS	0	0	0	0	0	MVLTRAKAS	40l28_NM_001271	0.0479000	29777.6	26.7135	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	9
9	HLA-C*07:01	LTRAKALEL	LTRAKALEL	0	0	0	0	0	LTRAKALEL	40l28_NM_001271	0.3013380	1918.6	0.6416	WB	9	HLA-C*07:01	LTRAKASEL	LTRAKASEL	0	0	0	0	0	LTRAKASEL	40l28_NM_001271	0.2479280	3419.5	1.1867	WB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	7
10	HLA-C*07:01	TRAKALEL	TRA-KALEL	0	0	0	3	1	TRAKALEL	40l28_NM_001271	0.2369370	3851.3	1.3536	WB	10	HLA-C*07:01	TRAKASEL	TRA-KASEL	0	0	0	3	1	TRAKASEL	40l28_NM_001271	0.1683740	8087.0	3.2163	nonB	NM_001271441	c.C44T	p.S15L	protein-altering	MKLTRKMVLTRAKALELHSVRKLNCWGSR	MKLTRKMVLTRAKASELHSVRKLNCWGSR	21	45759034	.	G	A	225	PASS	DP=552;VDB=3.677383e-01;RPB=-8.902372e-01;AF1=0.5;AC1=1;DP4=206,66,114,25;MQ=60;FQ=225;PV4=0.11,0.0007,1,1;ACGTNacgtnPLUS=54,0,107,0,0,31,0,94,0,0;ACGTNacgtnMINUS=63,0,98,0,0,31,0,56,0,0	GT:PL:GQ	0/1:255,0,255:99	GTGCAGCTCC,AGGCCTTGGC	DP=161;DP5=96,60,0,0,0;DP5all=100,61,0,0,0;ACGTNacgtnHQ=0,0,96,0,0,0,0,60,0,0;ACGTNacgtn=0,0,100,0,0,0,0,61,0,0;VAF=0.00;TSR=0;PBINOM=1.09476442525377e-47	somatic	.	.	exonic	C21orf2	nonsynonymous SNV	C21orf2:ENST00000397956.3:exon1:c.C44T:p.S15L,C21orf2:ENST00000325223.7:exon1:c.C44T:p.S15L,C21orf2:ENST00000339818.4:exon1:c.C44T:p.S15L,	.	21q22.3	.	.	.	.	.	1	.	10	somatic	.	0	0	0	0	.	CpG_26881	.	125	.	.	.	.	CGI(7%);score=93	PCS_2913798;score=582	IRF1&TBL1XR1&POLR2A&SP4&PHF8&TAF7&YY1&CEBPD&EGR1&MAX&CTBP2&MYC&CCNT2	6
